<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Dose Response</journal-id><journal-id journal-id-type="iso-abbrev">Dose Response</journal-id><journal-id journal-id-type="publisher-id">DOS</journal-id><journal-id journal-id-type="hwp">spdos</journal-id><journal-title-group><journal-title>Dose-Response</journal-title></journal-title-group><issn pub-type="epub">1559-3258</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6328957</article-id><article-id pub-id-type="doi">10.1177/1559325818813227</article-id><article-id pub-id-type="publisher-id">10.1177_1559325818813227</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Natural Products Mediated Targeting of Virally Infected Cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fatima</surname><given-names>Iram</given-names></name><xref ref-type="aff" rid="aff1-1559325818813227">1</xref></contrib><contrib contrib-type="author"><name><surname>Kanwal</surname><given-names>Sobia</given-names></name><xref ref-type="aff" rid="aff2-1559325818813227">2</xref></contrib><contrib contrib-type="author"><name><surname>Mahmood</surname><given-names>Tariq</given-names></name><xref ref-type="aff" rid="aff1-1559325818813227">1</xref><xref ref-type="corresp" rid="corresp1-1559325818813227"/></contrib></contrib-group><aff id="aff1-1559325818813227">
<label>1</label>Department of Plant Sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan</aff><aff id="aff2-1559325818813227">
<label>2</label>Department of Zoology, University of Gujrat Sub-campus Rawalpindi, Rawalpindi, Pakistan</aff><author-notes><corresp id="corresp1-1559325818813227">Tariq Mahmood, Department of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan. Email: <email>tmahmood@qau.edu.pk</email></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><season>Jan-Mar</season><year>2019</year></pub-date><volume>17</volume><issue>1</issue><elocation-id>1559325818813227</elocation-id><history><date date-type="received"><day>17</day><month>2</month><year>2018</year></date><date date-type="rev-recd"><day>1</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>10</day><month>10</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by-nc/4.0/">http://www.creativecommons.org/licenses/by-nc/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><abstract><p>The role of viral infection in developing cancer was determined in the start of 20th century. Until now, 8 different virus-associated cancers have been discovered and most of them progressed in immunosuppressed individuals. The aim of the present study is to look into the benefits of natural products in treating virally infected cancers. The study focuses on bioactive compounds derived from natural sources. Numerous pharmaceutical agents have been identified from plants (vincristine, vinblastine, stilbenes, combretastatin, and silymarin), marine organisms (bryostatins, cephalostatin, ecteinascidins, didemnin, and dolastatin), insects (cantharidin, mastoparan, parectadial, and cecropins), and microorganisms (vancomycin, rhizoxin, ansamitocins, mitomycin, and rapamycin). Beside these, various compounds have been observed from fruits and vegetables which can be utilized in anticancer therapy. These include curcumin in turmeric, resveratrol in red grapes, S-allyl cysteine in allium, allicin in garlic, catechins in green tea, and &#x003b2;-carotene in carrots. The present study addresses various types of virally infected cancers, their mechanism of action, and the role of different cell surface molecules elicited during viral binding and entry into the target cell along with the anticancer drugs derived from natural products by targeting screening of bioactive compounds from natural sources.</p></abstract><kwd-group><kwd>virus</kwd><kwd>cancer</kwd><kwd>cell surface molecules</kwd><kwd>natural sources</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>January-March 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="section1-1559325818813227"><title>Introduction</title><p>An unusual growth of cells that propagates through unlimited cell division is termed as cancer. These cells also attack different tissues and then spread to other parts of the body. About 11 million people worldwide have been detected with cancer, which may approximately increase to 16 million by 2020.<sup><xref rid="bibr1-1559325818813227" ref-type="bibr">1</xref></sup> International Agency in Cancer Research estimated that viruses are the cause of almost 20% of aggregate cancers.<sup><xref rid="bibr2-1559325818813227" ref-type="bibr">2</xref></sup> Viral infection leads to chronic inflammation which proliferates growth of cancer cells. Nearly all of the tumor cells are at the mercy of virus for survival. Virally infected cancer is in fact major issue in low-income populations, developing countries, and immunosuppressed individuals from developed nations.</p><p>Generally, people of all ages may be affected by cancer, but risk tends to increase with age because DNA damages more easily with aging because of the mutations that occur at the cellular level and cause alterations in protein function and regulation.<sup><xref rid="bibr3-1559325818813227" ref-type="bibr">3</xref>,<xref rid="bibr4-1559325818813227" ref-type="bibr">4</xref></sup> Besides vaccination, surgery, radiotherapy, and drug therapy are used for the treatment of virus-associated human malignances. Dietary supplements and medicinal plants are proposed to prevent cancer development because of their long history of human utilization. This review elaborates different types of virally infected cancers and highlights the naturally derived products used for its treatment.</p></sec><sec id="section2-1559325818813227"><title>Historical Background</title><sec id="section3-1559325818813227"><title>Discovery of Associated Cancer Viruses</title><p>Viruses&#x02019; role as cancer-causing agents emerged in the beginning of 20th century.<sup><xref rid="bibr5-1559325818813227" ref-type="bibr">5</xref></sup> The tumor growth takes place by the cooperation of several events. To date, 8 cancer viruses have been discovered and are classified into 2 groups, that is, DNA and RNA tumor viruses on the basis of their genetic makeup (<xref rid="table1-1559325818813227" ref-type="table">Table 1</xref>).</p><table-wrap id="table1-1559325818813227" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Names of Viruses Along With Their Associated Malignancies.</p></caption><alternatives><graphic xlink:href="10.1177_1559325818813227-table1"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Serial Number</th><th rowspan="1" colspan="1">Viruses</th><th rowspan="1" colspan="1">Genome</th><th rowspan="1" colspan="1">Cancers</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">Epstein-Barr virus (EBV) (or HHV-4)</td><td rowspan="1" colspan="1">Double-stranded DNA herpesvirus (&#x0223c;172 kb)</td><td rowspan="1" colspan="1">Burkitt lymphoma, nasopharyngeal carcinoma</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref>
,<xref rid="bibr7-1559325818813227" ref-type="bibr">7</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">Kaposi sarcoma herpesvirus (KSHV) (or HHV-8)</td><td rowspan="1" colspan="1">Double-stranded DNA herpesvirus (&#x0223c;160 kb)</td><td rowspan="1" colspan="1">Primary effusion lymphoma, Kaposi sarcoma</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref>,<xref rid="bibr8-1559325818813227" ref-type="bibr">8</xref>,<xref rid="bibr9-1559325818813227" ref-type="bibr">9</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Human papilloma virus (HPV)</td><td rowspan="1" colspan="1">Double-stranded DNA papilloma virus (&#x0223c;8 kb)</td><td rowspan="1" colspan="1">Cervical, neck, head, and anogenital tract carcinoma</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref>,<xref rid="bibr10-1559325818813227" ref-type="bibr">10</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">Merkel cell polyomavirus (MCPV)</td><td rowspan="1" colspan="1">Double-stranded DNA polyomavirus (&#x0223c;5.4 kb)</td><td rowspan="1" colspan="1">Merkel cell carcinoma</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr11-1559325818813227" ref-type="bibr">11</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">Hepatitis B virus (HBV)</td><td rowspan="1" colspan="1">Partially double-stranded DNA hepadenovirus (&#x0223c;3.2 kb)</td><td rowspan="1" colspan="1">Hepatocellular carcinoma</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref>,<xref rid="bibr12-1559325818813227" ref-type="bibr">12</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">Hepatitis C virus (HCV)</td><td rowspan="1" colspan="1">Single-stranded RNA flavivirus (&#x0223c;9.6 kb)</td><td rowspan="1" colspan="1">Hepatocellular carcinoma, lymphomas</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr13-1559325818813227" ref-type="bibr">13</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">Human T-cell leukemia virus-1 (HTLV-1)</td><td rowspan="1" colspan="1">Single-stranded RNA retrovirus (&#x0223c;9.0 kb)</td><td rowspan="1" colspan="1">Adult T-cell leukemia</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref>,<xref rid="bibr14-1559325818813227" ref-type="bibr">14</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">Human immunodeficiency virus (HIV)</td><td rowspan="1" colspan="1">Double-stranded RNA retroviridae (&#x0223c;9.7 kb)</td><td rowspan="1" colspan="1">Enhances immunosuppression-mediated cancers by other viruses</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref>,<xref rid="bibr15-1559325818813227" ref-type="bibr">15</xref></sup>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-1559325818813227"><p>Abbreviation: HHV, human herpesvirus.</p></fn></table-wrap-foot></table-wrap><sec id="section4-1559325818813227"><title>DNA tumor viruses</title><sec id="section5-1559325818813227"><title>Epstein-Barr virus</title><p>In 1964, Anthony Epstein, Bert Achong, and Yvonne Barr deduce Epstein-Barr virus (EBV) particles, also known as human herpesvirus 4 (HHV-4), in cell lines from African patients with Burkitt lymphoma.<sup><xref rid="bibr16-1559325818813227" ref-type="bibr">16</xref></sup> The EBV possesses linear double-stranded DNA (dsDNA) genome and favorably infect epithelial cells and B lymphocytes.<sup><xref rid="bibr17-1559325818813227" ref-type="bibr">17</xref></sup> The EBV is ubiquitous affecting more than 90% of adults.<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref></sup> Oral and blood are its principal route of transmission.<sup><xref rid="bibr18-1559325818813227" ref-type="bibr">18</xref></sup> During childhood, primary infection with EBV is mostly asymptomatic; nevertheless, the infected person is rendered a carrier for whole life. However, EBV infection during adolescence results in a disease called infectious mononucleosis.<sup><xref rid="bibr7-1559325818813227" ref-type="bibr">7</xref>,<xref rid="bibr19-1559325818813227" ref-type="bibr">19</xref></sup> In some cases, EBV infection leads to the development of carcinomas and lymphomas and non-Hodgkin lymphoma.<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref></sup> The virally encoded latent membrane protein 1 activates STAT and nuclear factor &#x003ba;B (NF-&#x003ba;B) transcription factors in B cells and PI3K in epithelial cells.<sup><xref rid="bibr20-1559325818813227" ref-type="bibr">20</xref></sup> It enhances the growth and survival of the infected cell.</p></sec><sec id="section6-1559325818813227"><title>Kaposi sarcoma-associated herpesvirus</title><p>Kaposi sarcoma-associated herpesvirus (KSHV) have linear dsDNA and remains in the nucleus as episomes even after infecting the cell.<sup><xref rid="bibr21-1559325818813227" ref-type="bibr">21</xref></sup> The KSHV, also known as HHV-8, is epidemic in sub-Saharan Africa (&#x0003e;50%), moderately spread in the Mediterranean region (10%-30%), and less in northern Europe, United States, and Asia (&#x0003c;10%).<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref></sup> Primary routes of KSHV transmission include blood transfusion, sexual contact, and organ transplant. The KSHV is the causative agent of lymphomas and sarcomas.<sup><xref rid="bibr22-1559325818813227" ref-type="bibr">22</xref></sup> The latency-associated nuclear antigen (LANA) plays a significant role in KSHV-associated tumorigenesis.<sup><xref rid="bibr8-1559325818813227" ref-type="bibr">8</xref>,
<xref rid="bibr9-1559325818813227" ref-type="bibr">9</xref></sup>
</p></sec><sec id="section7-1559325818813227"><title>Human papilloma virus</title><p>Human papilloma virus (HPV), which belongs to the Papillomaviridae family, is principally transmitted by skin contact even during sexual intercourse. Infection is controlled by the immune system, while, in some cases, HPV persists which further leads to the development of epithelial lesions.<sup><xref rid="bibr22-1559325818813227" ref-type="bibr">22</xref></sup> The HPV is highly prevalent in Africa and America (20%-30%).<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref></sup> It is classified into low-risk or high-risk groups depending on their cancer-causing potential. Moreover, HPV has greater tendency to develop skin cancers in immunosuppressed patients and other anogenital cancers.<sup><xref rid="bibr23-1559325818813227" ref-type="bibr">23</xref></sup>
</p></sec><sec id="section8-1559325818813227"><title>Merkel cell polyomavirus</title><p>Polyomaviruses have a circular, dsDNA of approximately 5000 bp. Merkel cell polyomavirus (MCPyV) is cosmopolitan and is found in about 80% of the tumors. Evidence revealed that oncogenic transformation of MCPyV occurs due to loss of immune surveillance, because Merkel cell carcinoma (MCC) was detected only in immunocompromised people.<sup><xref rid="bibr24-1559325818813227" ref-type="bibr">24</xref></sup>
</p></sec><sec id="section9-1559325818813227"><title>Hepatitis B virus</title><p>Hepatitis B virus (HBV) belongs to Hepadnaviridae family and has a potential to provoke liver disease in animals, including humans. The HBV is an enveloped virus comprising of a dsDNA chain along with a single-stranded fragment. The HBV infection may initiate in early childhood or during later stages of life.<sup><xref rid="bibr25-1559325818813227" ref-type="bibr">25</xref></sup> Long-lasting infections by HBV result in hepatocellular carcinoma (HCC). Both direct and indirect methods are involved in carcinogenesis process induced by HBV.<sup><xref rid="bibr26-1559325818813227" ref-type="bibr">26</xref></sup>
</p></sec></sec><sec id="section10-1559325818813227"><title>RNA tumor viruses</title><sec id="section11-1559325818813227"><title>Hepatitis C virus</title><p>Hepatitis C virus (HCV) is a positive-strand RNA virus which shows RNA polymerase activity and its genome includes roughly 9600 nucleotides.<sup><xref rid="bibr13-1559325818813227" ref-type="bibr">13</xref></sup> The HCV infects liver cells causing severe infection that may become chronic in immunosuppressed individuals, leading to hepatitis and HCC.<sup><xref rid="bibr27-1559325818813227" ref-type="bibr">27</xref></sup> All inclusive, about 170 million people are affected by HCV globally.<sup><xref rid="bibr28-1559325818813227" ref-type="bibr">28</xref></sup> The HCV transmission chiefly occurs through infected blood products. Nonstructural proteins (such as NS5) of HCV can derange signal transduction pathways, leading to cellular proliferation followed by cancerous development. Core protein of HCV also performs various functions including altered cellular gene transcription and cell death.<sup><xref rid="bibr29-1559325818813227" ref-type="bibr">29</xref></sup>
</p></sec><sec id="section12-1559325818813227"><title>Human T-lymphotropic virus type 1</title><p>Human T-lymphotropic virus type 1 (HTLV-1) is associated with a range of lymphoproliferative diseases such as adult T-cell lymphoma (ATL).<sup><xref rid="bibr14-1559325818813227" ref-type="bibr">14</xref></sup> Currently, about 15 to 25 million people have been affected with HTLV-1 worldwide. Vertical, sexual, and parenteral are 3 fundamental routes of HTLV-1 transmission. The viral-encoded Tax protein acts as a major oncogenic determinant of HTLV-1 by directly interacting with several signaling cascades and DNA repair pathways, increasing cell survival and transformation, instead of immunomodulatory response mediating inflammation as involved in case of other cancers.<sup><xref rid="bibr30-1559325818813227" ref-type="bibr">30</xref></sup>
</p></sec><sec id="section13-1559325818813227"><title>Human immunodeficiency virus</title><p>HIV is a retrovirus that induces immunodeficiency, which in turn assists the cancer cell progression caused by other viruses. HIV does not directly cause cancer.<sup><xref rid="bibr2-1559325818813227" ref-type="bibr">2</xref></sup> Presently, 33.3 million people are infected with HIV.<sup><xref rid="bibr6-1559325818813227" ref-type="bibr">6</xref></sup> Principal routes of HIV-1 infection include sexual intercourse and via blood contact.<sup><xref rid="bibr15-1559325818813227" ref-type="bibr">15</xref></sup>
</p></sec></sec></sec></sec><sec id="section14-1559325818813227"><title>Cancer Development in Immunocompromised Individuals</title><p>International Agency for Research on Cancer determined that 1 of 5 cancer victims are due to infection and nearly all of them are caused by viruses.<sup><xref rid="bibr2-1559325818813227" ref-type="bibr">2</xref></sup> These are notably universal health problems for underprivileged as well as immunosuppressed individuals. Up till now, evidences confirmed that the evasion of inherent immunity plays a vital role in viral oncogenesis. Inborn immune surveillance signaling along with cancer suppressor signaling processes initiates apoptotic pathways.<sup><xref rid="bibr31-1559325818813227" ref-type="bibr">31</xref></sup> Hence, targeting of tumor suppressor pathways by viruses depicts an immune evasion response that impairs antiviral pathways but keeps the affected cell at danger for cancerous growth (known as anti-antivirus hypothesis). The 2-fold nature of inborn immune signaling in antivirus and anticancer functions is characterized by interferon regulatory factors.<sup><xref rid="bibr32-1559325818813227" ref-type="bibr">32</xref></sup>
</p><p>The KSHV encodes 4 interferon regulatory factor homologues,<sup><xref rid="bibr33-1559325818813227" ref-type="bibr">33</xref></sup> which inhibit interferon signaling and initiate cell transformation. Other established KSHV oncoproteins, namely, interleukin-6 (IL-6),<sup><xref rid="bibr34-1559325818813227" ref-type="bibr">34</xref></sup> latent nuclear antigen-1 (LANA1), and LANA2,<sup><xref rid="bibr35-1559325818813227" ref-type="bibr">35</xref>,<xref rid="bibr36-1559325818813227" ref-type="bibr">36</xref></sup> also clearly describe the inherent immunomodulatory roles. Of EBV-associated cancers, non-Hodgkin lymphoma and Hodgkin lymphoma are chronic in immunosuppressed individuals compared to common population.<sup><xref rid="bibr2-1559325818813227" ref-type="bibr">2</xref></sup>
</p><p>Merkel cell carcinoma is more recurrent in patients with AIDS than in general people.<sup><xref rid="bibr37-1559325818813227" ref-type="bibr">37</xref></sup> Evidences revealed that the replication of several polyomaviruses increases in immunosuppressed individuals, thereby illustrating the role of immune system in MCC development. Similarly, HPV and squamous intraepithelial lesions diagnosis in HIV-infected women is greatly linked to high viral load.<sup><xref rid="bibr38-1559325818813227" ref-type="bibr">38</xref></sup> So, the initial stages of HPV replication leading to cervical cancer may be affected by HIV-associated immune suppression.<sup><xref rid="bibr39-1559325818813227" ref-type="bibr">39</xref></sup> Moreover, ATL, also known as human T-lymphotropic virus type 1 (HTLV-I), is also more frequent in immunodeficient individuals than the general people.<sup><xref rid="bibr40-1559325818813227" ref-type="bibr">40</xref></sup> Hence, viral replication is modulated by immune system and these virus-mediated cancers increases in immune suppression cases due to the host inability to curb viral replication and the development of infected cells. Immune effector cells recognize viral proteins and direct tumor cell growth.</p></sec><sec id="section15-1559325818813227"><title>Mechanism of Virus-Mediated Carcinogenesis</title><p>Virus-mediated carcinogenesis involves initiation, promotion, and progression in order to change an ordinary cell into oncogenic cell. Initiation involves a reaction between carcinogen and the DNA of tissue cells. The second stage is promotion during which cell proliferation occurs and it happens gradually from few months to years. Change in eating routine along with way of life can have a helpful impact at this stage so that the person may not develop cancer. The last stage involves progression and spread of the tumor. Diet may have less impact at this stage.</p><p>Cancer causes the death of the host, and in this way, it ceases the infection. Incorrect diet, genetic susceptibility, and the environmental factors (air and water pollution, radiation, etc) predominantly cause cancer. About 35% of cancers are caused by inappropriate diet and 20% of cancers are because of genetic predisposition. In this manner, remaining cancer cases are related to ecological cancer-causing agents.<sup><xref rid="bibr41-1559325818813227" ref-type="bibr">41</xref></sup>
</p><sec id="section16-1559325818813227"><title>Direct Mechanism of Viral Carcinogenesis</title><p>For direct carcinogenesis, viruses have developed a plethora of events to hijack different cellular processes (<xref ref-type="fig" rid="fig1-1559325818813227">Figure 1</xref>).</p><fig id="fig1-1559325818813227" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Direct mechanism of viral carcinogenesis. After infecting cells, tumor infections are kept as hereditary components; viral genomes can form episomes or integrate into the host genomic DNA.</p></caption><graphic xlink:href="10.1177_1559325818813227-fig1"/></fig><sec id="section17-1559325818813227"><title>Virus-encoded genes that activate growth</title><p>Viral or cellular oncogenes are direct-acting agents found in the form of a single clone inside the tumor cells. Expression of such genes enhances the resistance to apoptosis, which ultimately results in modifications in DNA repair mechanisms. For example, inactivation of p53 and pRb tumor suppressor genes mostly occurs during viral oncogenesis.<sup><xref rid="bibr42-1559325818813227" ref-type="bibr">42</xref></sup> When DNA is damage, p53, that is, product of the <italic>TP53</italic> gene, inhibits cell cycle until the damage is restored. Otherwise, p53 induces cell senescence if it does not occur. The viral inactivation of p53 has been observed in E6 protein from HPV and in LANA1 expressed by KSHV.<sup><xref rid="bibr43-1559325818813227" ref-type="bibr">43</xref></sup>
</p></sec><sec id="section18-1559325818813227"><title>Genomic instability</title><p>The tendency of genome is increased to acquire mutations. For example, EBV Epstein&#x02013;Barr nuclear antigen (EBNA)-1 may cause genomic instability by activating recombinase-activating genes (<italic>RAG1</italic> and <italic>RAG2</italic>).<sup><xref rid="bibr5-1559325818813227" ref-type="bibr">5</xref></sup> Similarly, HBx alters the centrosome function by forming complex with HBx interacting protein.<sup><xref rid="bibr44-1559325818813227" ref-type="bibr">44</xref></sup>
</p></sec><sec id="section19-1559325818813227"><title>Interfering with telomere shortening</title><p>Infinite cell proliferation normally results in telomere shortening and eventually leads to cell death. Oncogenic viruses also maintain telomere with the help of enzyme telomerase along with various proteins.<sup><xref rid="bibr45-1559325818813227" ref-type="bibr">45</xref></sup> Telomerase expression is observed only in cells with stem properties, such as germinal cells. To date, HPV E6, KSHV LANA, HBV HBx, and HTLV1 Tax have been shown to cause the telomerase expression.<sup><xref rid="bibr46-1559325818813227" ref-type="bibr">46</xref></sup>
</p></sec><sec id="section20-1559325818813227"><title>Interfering with cell polarity</title><p>Viral oncoproteins also inactivate proteins related to cell polarity, which ultimately leads to oncogenesis by impairing morphogenesis and differentiation programs. For instance, postsynaptic density protein and zonula occludens-1 protein domains, which play a significant role in cell&#x02013;cell contact, generally interact with target proteins via PDZ domain-binding motif. A class I PBM was first identified in adenovirus 9 and later on observed in HPV E6 and HTLV1 Tax.<sup><xref rid="bibr47-1559325818813227" ref-type="bibr">47</xref></sup>
</p></sec><sec id="section21-1559325818813227"><title>Viral microRNAs</title><p>MicroRNAs (miRNAs) are about 22 nucleotides long that usually inhibit messenger RNA translation.<sup><xref rid="bibr48-1559325818813227" ref-type="bibr">48</xref></sup> Recent studies revealed that all cancers almost show altered expression of cellular miRNAs.<sup><xref rid="bibr49-1559325818813227" ref-type="bibr">49</xref></sup> The first 5 viral miRNAs with oncogenic capabilities were observed in EBV-positive B95 cell line. Till now, 40 miRNAs have been identified from EBV BARTs and BHFR1 transcripts.<sup><xref rid="bibr50-1559325818813227" ref-type="bibr">50</xref></sup> These miRNAs have tendency to inhibit apoptosis, while some target cellular tumor suppressor genes, such as <italic>PUMA</italic>, <italic>Bin</italic>, and <italic>WIF1</italic>.<sup><xref rid="bibr51-1559325818813227" ref-type="bibr">51</xref></sup>
</p></sec><sec id="section22-1559325818813227"><title>Indirect mechanism of viral carcinogenesis</title><p>The indirect transforming viruses do not reside inside the tumor cells and generally act through following mechanisms (<xref ref-type="fig" rid="fig2-1559325818813227">Figure 2</xref>).</p><fig id="fig2-1559325818813227" orientation="portrait" position="float"><label>Figure 2.</label><caption><p>Indirect mechanisms of viral carcinogenesis. A, Chronic inflammation. Affected cells produce cytokines, chemokines attracting insusceptible cells, which harm the local tissue. Cancer develops inside this cycle of infection and causes inflammation. B, Immunosuppression. The model operator for immunosuppression is HIV. Epstein-Barr virus (EBV) infection is mostly controlled by cytotoxic CD8T cells; as HIV disease progresses and immune system is suppressed, people get to be at increased danger of having EBV-related lymphomas.</p></caption><graphic xlink:href="10.1177_1559325818813227-fig2"/></fig></sec><sec id="section23-1559325818813227"><title>Chronic inflammation</title><p>Cells of the immune system proliferate as a result of infection and induce local damage to tissues identified by the formation of pro-inflammatory cytokines, chemokines, and antiapoptotic genes that stimulate endothelial cells to divide along with recasting tissues and neovascularization.<sup><xref rid="bibr52-1559325818813227" ref-type="bibr">52</xref></sup> Common viral agents that act through chronic inflammation are HBV and HCV.</p></sec><sec id="section24-1559325818813227"><title>Immunosuppression</title><p>Viruses cause immunosuppression which indirectly reduces antitumor immune surveillance mechanisms. For instance, immunosuppression generated by HIV infection leads to the cancer development.<sup><xref rid="bibr53-1559325818813227" ref-type="bibr">53</xref></sup>
</p></sec><sec id="section25-1559325818813227"><title>Oncomodulation</title><p>Viruses also take part in carcinogenesis by curbing the usual process of an already established cancer. The term &#x0201c;oncomodulation&#x0201d; was proposed by Martin Michaelis to express the function of human cytomegalovirus (HCMV) in tumor growth.<sup><xref rid="bibr54-1559325818813227" ref-type="bibr">54</xref></sup>
</p></sec></sec></sec><sec id="section26-1559325818813227"><title>Antiviral Defense Pathways Induced by Cells and Molecules Elicited During Viral Infections</title><p>Viruses, a class of intracellular pathogens, form different factors for invulnerability against these pathogens. Particular viral infections differ from others in magnitude and composition as well as in response to various cells and molecules. Studies demonstrated that many cell surface molecules are produced amid viral binding and entry into the host cell which actuates different but overlapping antiviral defense pathways. Foremost among these are discussed below.</p><sec id="section27-1559325818813227"><title>Interferons &#x003b1; and &#x003b2;</title><p>Interferons &#x003b1; and &#x003b2; (IFN-&#x003b1;/&#x003b2;) are also known as type 1 interferons. Amid certain viral diseases, high levels of IFN-&#x003b1;/&#x003b2; are evoked in the host and intercede the immunoregulatory effects.<sup><xref rid="bibr55-1559325818813227" ref-type="bibr">55</xref></sup> The IFN-&#x003b1;/&#x003b2;-induced cellular antiviral response is the primary defense against a viral disease. The ultimate changes caused by IFN-&#x003b1;/&#x003b2; are control of cytokine receptor gene expression,<sup><xref rid="bibr56-1559325818813227" ref-type="bibr">56</xref></sup> activation of natural killer (NK) cell cytotoxic activity, and memory CD8 T-cell proliferation.<sup><xref rid="bibr57-1559325818813227" ref-type="bibr">57</xref></sup> Many viruses including both DNA and RNA viruses are sensitive to interferons-mediated antiviral effects.<sup><xref rid="bibr58-1559325818813227" ref-type="bibr">58</xref></sup>
</p></sec><sec id="section28-1559325818813227"><title>Tumor Necrosis Factors and IFN-&#x003b3;</title><p>Both IFN-&#x003b3; and tumor necrosis factor (TNF) are elicited at early times amid certain viral diseases.<sup><xref rid="bibr59-1559325818813227" ref-type="bibr">59</xref></sup> The pathways evoked by TNF and IFN coincide with those prompted by IFN-&#x003b1;/&#x003b2;. The TNF is weaker, yet collaborates with IFN-&#x003b1;/&#x003b2; for these effects. Whereas IFN-&#x003b3; is a strong activator, TNF combines with IFN-&#x003b1;/&#x003b2; to activate macrophages that can mediate resistance through inducible nitric oxide synthase&#x02013;dependent pathways successful in damaging other pathogens. The nitric oxide synthase (NOS<sub>2</sub>) enzyme catalyzes nitric oxide NO, which reacts with oxygen and its intermediates to yield various molecules capable of altering vital components for virus replication.<sup><xref rid="bibr60-1559325818813227" ref-type="bibr">60</xref></sup>
</p></sec><sec id="section29-1559325818813227"><title>Cytotoxic T Lymphocytes</title><p>The HBV-specific cytotoxic T lymphocytes (CTLs) inhibit viral gene replication in the liver by mechanism that is interceded by IFN-&#x003b3; and TNF-&#x003b1;. Hence, CTLs have ability to kill infected hepatocytes and cause liver infection or suppress viral replication and alleviate the infection.<sup><xref rid="bibr61-1559325818813227" ref-type="bibr">61</xref></sup>
</p></sec><sec id="section30-1559325818813227"><title>Interleukin 12</title><p>Although IFN-&#x003b1;/&#x003b2; cytokines canal on negatively controlled IL-12 expression, IL-12 is produced in particular viral diseases and activates NK cell IFN-&#x003b3; and creates normal Th1 responses. The TNF stimulates IL-12 induction of NK cell IFN-&#x003b3; production. Besides promoting defense mechanisms, IL-12 also mediates IFN-&#x003b3;-independent mechanisms.<sup><xref rid="bibr62-1559325818813227" ref-type="bibr">62</xref></sup>
</p></sec><sec id="section31-1559325818813227"><title>Double-Stranded RNA</title><p>Although double-stranded RNA (dsRNA) is absent in normal cells, it is often produced in cells as a consequence of viral replication. In the presence of dsRNA, (2&#x02032;-9&#x02032;)-oligoadenylate synthetase and the dsRNA-dependent protein kinase (PKR) stimulate inhibition of host cell protein synthesis and thus hinder viral replication.<sup><xref rid="bibr58-1559325818813227" ref-type="bibr">58</xref></sup>
</p></sec><sec id="section32-1559325818813227"><title>Heparin-Derived Molecules</title><p>Sometimes heparin-derived molecules are generated as a result of viral infection. For example, herpesvirus and HHV-8 utilize HS molecules for viral binding and entry. Heparin can effectively inhibit HCVcc, HCV-LP, and HCVpp binding to hepatoma cells.<sup><xref rid="bibr63-1559325818813227" ref-type="bibr">63</xref></sup>
</p></sec><sec id="section33-1559325818813227"><title>Scavenger Receptor Class B Type I and Serum Amyloid</title><p>In some cases, scavenger receptor class B type I binds and internalizes serum amyloid A (SAA) protein that mediates the pro-inflammatory cellular responses. The SAA has the ability to inhibit HCV entry and thus reduces its infectivity.<sup><xref rid="bibr64-1559325818813227" ref-type="bibr">64</xref></sup>
</p></sec><sec id="section34-1559325818813227"><title>Lectin Cyanovirin-N</title><p>Recently, another active compound, that is, lectin cyanovirin-N, has been discovered against HIV and showed potent antiviral activity against other viruses.<sup><xref rid="bibr65-1559325818813227" ref-type="bibr">65</xref></sup> Lectin cyanovirin-N and high-mannose oligosaccharides amalgamate present on viral envelope glycoproteins inhibit the viral entry. However, in HCV, mostly the glycosylation sites are so conserved that drugs targeting glycoproteins are unable to escape from virus as rapidly as in case of HIV does.<sup><xref rid="bibr66-1559325818813227" ref-type="bibr">66</xref></sup>
</p></sec><sec id="section35-1559325818813227"><title>Phosphorothioate Oligonucleotides and Other Carbohydrate-Binding Agents</title><p>Antiviral compounds directing viral passage sometimes target particular cell surface molecules. Studies revealed that amphipathic DNA polymer, namely, phosphorothioate oligonucleotides, exhibits significant activity against HIV by blocking virus&#x02013;cell fusion.<sup><xref rid="bibr67-1559325818813227" ref-type="bibr">67</xref></sup> Other carbohydrate-binding agents including plant lectins and the mannose-specific antibiotic pradimicin A prevent HIV infection.<sup><xref rid="bibr68-1559325818813227" ref-type="bibr">68</xref></sup> Such compounds may also be effective against other viruses that require a glycosylated envelope for entry into host cells.</p></sec><sec id="section36-1559325818813227"><title>Cyclin-Dependent Kinases</title><p>Human immunodeficiency virus type 1 (HIV-1) is the causative agent of AIDS. Cyclin-dependent kinases (cdks) are required for HIV-1 transcription, and thus, particular cdk inhibitors act as antiviral agents in the treatment of AIDS. Likewise, HCMV is a herpesvirus that activates cdk upon infection, which controls cell cycle in G1 and S phases. Consequently, the inhibition of cdk activity blocks HCMV replication.<sup><xref rid="bibr69-1559325818813227" ref-type="bibr">69</xref></sup>
</p></sec><sec id="section37-1559325818813227"><title>Cellular Proteins Prohibitin 1 and 2</title><p>Cellular protein prohibitin-1 (PHB1) exhibits antiproliferative activity, while PHB2, also known as repressor of estrogen receptor activity, curbs the estrogen receptor&#x02013;dependent gene activation.<sup><xref rid="bibr70-1559325818813227" ref-type="bibr">70</xref></sup> Both PHB1 and PHB2 are generally present on the plasma membrane, cytosol, and nucleus. They mediate HCV entry at a postbinding step via interacting with signaling molecule CRaf. However, removal of the entire C-terminal domains of PHB1 and PHB2 stops the interaction between PHB and CRaf. Such PHB-CRaf interaction can be jammed using natural products, such as rocaglamide (Roc-A), that will inhibit subsequent HCV entry into target cell. Henceforth, PHB1 and PHB2 are pan-genomic HCV entry factors.<sup><xref rid="bibr71-1559325818813227" ref-type="bibr">71</xref></sup>
</p></sec><sec id="section38-1559325818813227"><title>Integrin-Mediated Activation of Focal Adhesion Kinase</title><p>Integrin 31 is a cellular receptor for KSHV entry into the target cells. Human herpesvirus 8 is involved in the pathogenesis of Kaposi sarcoma. The HHV-8 envelope glycoprotein has arginylglycylaspartic acid (RGD) motif that synergizes with integrin molecules, and HHV-8 infectivity is blocked by RGD peptides and antibodies against RGD-dependent &#x003b1;3 and &#x003b2;1 integrins. Moreover, HHV-8 infection leads to the integrin-mediated activation of focal adhesion kinase (FAK). Hence, HHV-8 utilizes integrin and the associated signaling pathways to enter the cells. Activation of FAK and integrin-linked kinases is involved in signaling by integrins, actin assembly, and endocytosis.<sup><xref rid="bibr72-1559325818813227" ref-type="bibr">72</xref></sup> So, FAK activation has a central role in HHV-8 infection.</p></sec><sec id="section39-1559325818813227"><title>2B4 Molecules</title><p>2B4 is a surface molecule that activates the NK-cell-mediated cytotoxicity. It binds Src homology 2 domain-containing protein (SH2D1A) or signaling lymphocyte activation molecule-associated protein (SAP), which regulates 2B4-associated signal transduction pathway. So, 2B4 molecules also play significant role in infected cells such as in EBV.<sup><xref rid="bibr73-1559325818813227" ref-type="bibr">73</xref></sup>
</p></sec><sec id="section40-1559325818813227"><title>Bay 11-7082, an Inhibitor of NF-&#x003ba;B</title><p>T-cell lines infected with HTLV-I and leukemic cells show high activity of transcription factor NF-&#x003ba;B. Bay 11-7082, an inhibitor of NF-&#x003ba;B, induces apoptosis of HTLV-I-infected T-cell lines. Bay 11-7082 reduces the DNA binding of NF-&#x003ba;B in HTLV-I-infected T-cell lines and downregulates the expression of antiapoptotic gene, <italic>Bcl-x<sub>L</sub></italic>, that is regulated by NF-&#x003ba;B. In short, NF-&#x003ba;B is an appropriate target for the treatment of ATL.<sup><xref rid="bibr74-1559325818813227" ref-type="bibr">74</xref></sup>
</p></sec><sec id="section41-1559325818813227"><title>Tax</title><p>Tax initiates viral gene expression and activates the expression of many genes through various transcription factors, such as NF-&#x003ba;B/Rel, AP-1, and serum response factor.<sup><xref rid="bibr75-1559325818813227" ref-type="bibr">75</xref></sup> Normally, genes induced by Tax include cytokines/chemokines (IL-1a, IL-6, IL-8, TNF-&#x003b2;, and granulocyte colony-stimulating factor), their receptors, cell adhesion molecule (OX40), apoptosis inhibitor (Bcl-x<sub>L</sub>), and G1 cyclins.<sup><xref rid="bibr76-1559325818813227" ref-type="bibr">76</xref></sup> The transcriptional activation of genes deregulates the growth of HTLV-I-infected cells.</p></sec><sec id="section42-1559325818813227"><title>Influenza Virus NS1 Protein</title><p>Influenza virus NS1 protein prevents the PKR-mediated antiviral response. The PKR upon activation forms a dimer and autophosphorylates. The PKR blocks the protein synthesis, which ultimately prevents viral replication. Some viruses have set up certain approaches to block the PKR activity to mitigate the effects of PKR activation. For instance, influenza A virus can curb PKR activity by recruiting cellular protein P58IPK, which binds directly to kinase.<sup><xref rid="bibr77-1559325818813227" ref-type="bibr">77</xref></sup>
</p></sec><sec id="section43-1559325818813227"><title>Interferon Gamma Inducing Factor and Transforming Growth Factors</title><p>Interferon gamma inducing factor and transforming growth factor can be elicited by cells of the innate immune system as well as by other nonimmune cells. They also play a vital role in the clearance of many pathogens.<sup><xref rid="bibr78-1559325818813227" ref-type="bibr">78</xref></sup>
</p></sec><sec id="section44-1559325818813227"><title>Other Molecules</title><p>Other molecules involved in immunoregulatory system during chronic viral infections include claudin-1, occludin, epidermal growth factor receptor, low-density lipoprotein receptor, and DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3 grabbing nonintegrin)/L-SIGN (DC-SIGNr, liver and lymph node specific).<sup><xref rid="bibr79-1559325818813227" ref-type="bibr">79</xref><xref rid="bibr80-1559325818813227" ref-type="bibr"/><xref rid="bibr81-1559325818813227" ref-type="bibr"/><xref rid="bibr82-1559325818813227" ref-type="bibr"/>-<xref rid="bibr83-1559325818813227" ref-type="bibr">83</xref></sup>
</p></sec></sec><sec id="section45-1559325818813227"><title>Natural Products as a Robust Source for Cancer Chemoprevention</title><p>In the most obvious way, a &#x0201c;natural product&#x0201d; is a minute particle made by a biological source. In this manner, a natural product is a biologically dynamic chemical substance present in nature and generated by a living creature. For the most part, the expression &#x0201c;natural product&#x0201d; is viewed as being synonymous with &#x0201c;secondary metabolite.&#x0201d; Natural products are actually extremely small particles with a molecular weight below 3000 Da.<sup><xref rid="bibr84-1559325818813227" ref-type="bibr">84</xref></sup>
</p><p>Natural products, isolated from microorganisms, insects, dietary products, and medicinal plants, have been the greatest wellspring of hostile to malignancy drugs.<sup><xref rid="bibr85-1559325818813227" ref-type="bibr">85</xref></sup> From the earliest starting point, people are relying on nature for their essential requirements for the creation of sustenance stuffs, composts, and drugs, too. Respective conventional sources for secondary metabolites or natural products are elaborated in the following sections.</p><sec id="section46-1559325818813227"><title>Natural Products From Microorganisms</title><p>Billions of microorganisms are available ashore, in freshwater, and all territories of the ocean and the biosphere activities rely on this microbial world.<sup><xref rid="bibr86-1559325818813227" ref-type="bibr">86</xref></sup> The microbial world is an immense untapped asset for drug discovery. Truly, microorganisms have assumed an imperative part in giving new structures, similar to anti-infection agents for medication disclosure and advancement. Actinomycetes, for case, include numerous unrecognized secondary metabolites. Cyanophytes, also known as blue-green algae, are probably the most productive makers of medications utilized for cancer treatment. Illustrations incorporate coibamide A<sup><xref rid="bibr65-1559325818813227" ref-type="bibr">65</xref></sup> segregated from basic extraction of wild collects or fermentation of purified living beings.<sup><xref rid="bibr87-1559325818813227" ref-type="bibr">87</xref></sup> Extremophilic microbes are those living in extreme environments, including acidophiles, alkalophiles, hyperthermophiles, and psychrophiles.<sup><xref rid="bibr88-1559325818813227" ref-type="bibr">88</xref><xref rid="bibr89-1559325818813227" ref-type="bibr"/>-<xref rid="bibr90-1559325818813227" ref-type="bibr">90</xref></sup> Examples of natural compounds isolated from various microorganisms that are effectively used as anticancer agents are given in <xref rid="table2-1559325818813227" ref-type="table">Table 2</xref>.</p><table-wrap id="table2-1559325818813227" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Natural Compounds From Microorganisms Used as a Source of Anticancer Agents.</p></caption><alternatives><graphic xlink:href="10.1177_1559325818813227-table2"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Serial Number</th><th rowspan="1" colspan="1">Microorganism Name</th><th rowspan="1" colspan="1">Bioactive Compounds</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">
<italic>Amycolatopsis orientalis</italic>
</td><td rowspan="1" colspan="1">Vancomycin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr91-1559325818813227" ref-type="bibr">91</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">
<italic>Actinosynnema pretiosum</italic>
</td><td rowspan="1" colspan="1">Ansamitocins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr92-1559325818813227" ref-type="bibr">92</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">
<italic>Gymnodinium</italic> species</td><td rowspan="1" colspan="1">GA3P, a <sc>d</sc>-galactan sulfate</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr93-1559325818813227" ref-type="bibr">93</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">
<italic>Streptomyces pneuceticus</italic>
</td><td rowspan="1" colspan="1">Doxorubicin, daunorubicin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr94-1559325818813227" ref-type="bibr">94</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">
<italic>Talaromyces wortmanni</italic>
</td><td rowspan="1" colspan="1">Wortmannin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr95-1559325818813227" ref-type="bibr">95</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">
<italic>Chromobacterium violaceum</italic>
</td><td rowspan="1" colspan="1">Depsipeptide</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr96-1559325818813227" ref-type="bibr">96</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">
<italic>Burkholderia rhizoxina</italic>
</td><td rowspan="1" colspan="1">Rhizoxin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr97-1559325818813227" ref-type="bibr">97</xref></sup>
</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="section47-1559325818813227"><title>Natural Products From Marine Organisms</title><p>Marine environment is an uncommon repository of bioactive natural products, a considerable number which displays basic features not found in terrestrial natural products. The seas cover more than 70% of earth&#x02019;s surface. Marine life forms contain roughly 50% of the aggregate biodiversity on earth and the marine biological system is the best source to find valuable drugs. By and large, 3000 new chemical substances have been recognized from marine creatures.<sup><xref rid="bibr98-1559325818813227" ref-type="bibr">98</xref></sup> Marine has a place with extremely differing basic classes, including steroids and peptides. The life forms yielding these bioactive marine mixes include invertebrate creatures, algae, fungi, and bacteria.<sup><xref rid="bibr99-1559325818813227" ref-type="bibr">99</xref></sup> Sessile marine spineless creatures, for example, sponges and tunicates, generally missing morphological resistance structures, have built up the biggest number of marine inferred secondary metabolites, including the absolute most fascinating drug applicants. During the 21st century, bigger rates of bioactive non chemical entitites (NCEs) were accounted for marine life forms in contrast with terrestrial creatures.</p><p>The primary anticancer product didemnin B, secluded from the tunicate <italic>Trididemnum solidum</italic> from marine source, showed activity against non-Hodgkin lymphoma.<sup><xref rid="bibr100-1559325818813227" ref-type="bibr">100</xref></sup> Some ecteinascidins have been obtained from the tunicate <italic>Ecteinascidia turbinate</italic> possessing antitumor effects. Similarly, dolastatins obtained from <italic>Dolabella auricularia</italic> and bryostatins, isolated from <italic>Bugula neritina</italic> and other marine bryozoans, have demonstrated noteworthy activity against lymphocytic leukemia cell line.<sup><xref rid="bibr101-1559325818813227" ref-type="bibr">101</xref>,<xref rid="bibr102-1559325818813227" ref-type="bibr">102</xref></sup> Beside these, there are many other compounds isolated from marine life forms as potential antitumor agents, as given in <xref rid="table3-1559325818813227" ref-type="table">Table 3</xref>.</p><table-wrap id="table3-1559325818813227" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Natural Compounds From Marine Organisms Used as a Source of Anticancer Agents.</p></caption><alternatives><graphic xlink:href="10.1177_1559325818813227-table3"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Serial Number</th><th rowspan="1" colspan="1">Marine Organisms</th><th rowspan="1" colspan="1">Bioactive compounds</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">
<italic>Salinispora arenicola</italic>
</td><td rowspan="1" colspan="1">Saliniketals</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr102-1559325818813227" ref-type="bibr">102</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">
<italic>Marinispora</italic>
</td><td rowspan="1" colspan="1">Marinomycins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr103-1559325818813227" ref-type="bibr">103</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">
<italic>Cacospongia mycofijiensis</italic>
</td><td rowspan="1" colspan="1">Laulimalide</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr104-1559325818813227" ref-type="bibr">104</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">
<italic>Crambe crambe</italic>
</td><td rowspan="1" colspan="1">Crambescidin 800</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr105-1559325818813227" ref-type="bibr">105</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">
<italic>Dactylospongia elegans</italic>
</td><td rowspan="1" colspan="1">Smenospongine</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr105-1559325818813227" ref-type="bibr">105</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">
<italic>Discodermia dissolute</italic>
</td><td rowspan="1" colspan="1">Discodermolide</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr104-1559325818813227" ref-type="bibr">104</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">
<italic>Erythropodium caribaeorum</italic>
</td><td rowspan="1" colspan="1">Eleutherobin (diterpene glycoside)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr104-1559325818813227" ref-type="bibr">104</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">
<italic>Mycale hentscheli</italic>
</td><td rowspan="1" colspan="1">Peloruside A</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr106-1559325818813227" ref-type="bibr">106</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">9.</td><td rowspan="1" colspan="1">
<italic>Poecillastra</italic> species</td><td rowspan="1" colspan="1">Psammaplin A</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr107-1559325818813227" ref-type="bibr">107</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">10.</td><td rowspan="1" colspan="1">
<italic>Amphimedon</italic> species</td><td rowspan="1" colspan="1">Ascididemin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr108-1559325818813227" ref-type="bibr">108</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">11.</td><td rowspan="1" colspan="1">
<italic>Cephalodiscus gilchrist</italic>
</td><td rowspan="1" colspan="1">Cephalostatin 1</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr109-1559325818813227" ref-type="bibr">109</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">12.</td><td rowspan="1" colspan="1">
<italic>Cryptotheca crypta</italic>
</td><td rowspan="1" colspan="1">Cytarabine</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr110-1559325818813227" ref-type="bibr">110</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">13.</td><td rowspan="1" colspan="1">
<italic>Dolabella auricularia</italic>
</td><td rowspan="1" colspan="1">Dolastatins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr111-1559325818813227" ref-type="bibr">111</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">14.</td><td rowspan="1" colspan="1">
<italic>Bugula neritina</italic>
</td><td rowspan="1" colspan="1">Bryostatins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr112-1559325818813227" ref-type="bibr">112</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">15.</td><td rowspan="1" colspan="1">
<italic>Halichondria okadai</italic>
</td><td rowspan="1" colspan="1">Halichondrin B</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr113-1559325818813227" ref-type="bibr">113</xref></sup>
</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="section48-1559325818813227"><title>Natural Products From Insects</title><p>Insects make up around 75% of all species. Insects have provided profitable natural products, including honey (beeswax, pollen, and Royal Jelly) and silk, and have highlighted in pharmaceuticals for treating throat infection, tuberculosis, cancer, and numerous different maladies and afflictions for many years. Other than China, the utilization of insects in medicine is likewise basic in numerous different areas, including India and South Korea. Usually, the medicines are extricated from the stings of honeybees and wasps, or from their secretions, and after that teas made for drinking or treatments for external use.<sup><xref rid="bibr114-1559325818813227" ref-type="bibr">114</xref></sup>
</p><p>Stinging insects mostly produce venom containing an intricate mixture of various chemicals possessing various pharmacological functions. The entire body extracts of many wasps, butterflies, cockroaches, and beetles can also be used as anticancer agents. Moreover, insect antimicrobial peptides have been isolated from insects which kill microscopic organisms including bacteria, fungi, protozoans, and virally infected cancer cells.<sup><xref rid="bibr115-1559325818813227" ref-type="bibr">115</xref></sup> For example, cecropins can kill bacteria, fungi, protozoans, and cancer cells.<sup><xref rid="bibr116-1559325818813227" ref-type="bibr">116</xref></sup> Other compounds isolated from marine organisms that are successfully used as anticancer agents are given in <xref rid="table4-1559325818813227" ref-type="table">Table 4</xref>.</p><table-wrap id="table4-1559325818813227" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Natural Compounds From Insects Used as a Source of Anticancer Agents.</p></caption><alternatives><graphic xlink:href="10.1177_1559325818813227-table4"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Serial Number</th><th rowspan="1" colspan="1">Insects</th><th rowspan="1" colspan="1">Bioactive Compounds</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">
<italic>Parectatosoma mocquerysi</italic>
</td><td rowspan="1" colspan="1">Parectadial</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr114-1559325818813227" ref-type="bibr">114</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">
<italic>Drosophila melanogaster</italic>, <italic>Anopheles gambiae</italic>
</td><td rowspan="1" colspan="1">Cecropins (antimicrobial peptides)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr116-1559325818813227" ref-type="bibr">116</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Ants, bee, and wasp venom</td><td rowspan="1" colspan="1">Melittin, phospholipases and hyaluronidase</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr117-1559325818813227" ref-type="bibr">117</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">Paederus subspecies (rove beetle)</td><td rowspan="1" colspan="1">Pederin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr118-1559325818813227" ref-type="bibr">118</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">Honey bee</td><td rowspan="1" colspan="1">Fatty acid 10-hydroxy-2-decenoic acid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr119-1559325818813227" ref-type="bibr">119</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">
<italic>S. peregrine</italic>
</td><td rowspan="1" colspan="1">Lectin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr115-1559325818813227" ref-type="bibr">115</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">
<italic>Polybia polista</italic>
</td><td rowspan="1" colspan="1">Mastoparan</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr120-1559325818813227" ref-type="bibr">120</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">
<italic>Solenopsis invicta</italic>
</td><td rowspan="1" colspan="1">Solenopsin A (alkaloid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr121-1559325818813227" ref-type="bibr">121</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">9.</td><td rowspan="1" colspan="1">
<italic>Mylabris phalerata</italic> and <italic>Mylabris cichorii</italic>
</td><td rowspan="1" colspan="1">Cantharidin (terpenoid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr122-1559325818813227" ref-type="bibr">122</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">10.</td><td rowspan="1" colspan="1">
<italic>Pieris</italic> subspecies (butterfly)</td><td rowspan="1" colspan="1">Pierisin-1</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr123-1559325818813227" ref-type="bibr">123</xref></sup>
</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="section49-1559325818813227"><title>Dietary Natural Products</title><p>Undoubtedly, dietary sources play an essential role in cancers including fruits, vegetables, and spices, which yield bioactive components, namely, curcumin, isoflavones, saponins, and lycopene. Mounted evidences proposed that regular intake of a high-fiber, low-fat diet altogether with different fruits, legumes, and vegetables effectively reduces the cancer risks, as they possess various antioxidants which provide protection against harmful effects of free radicals that lead to the cancer development.<sup><xref rid="bibr124-1559325818813227" ref-type="bibr">124</xref></sup> However, saturated fats, salt, and sugar intake should be avoided or reduced in order to prevent cancer development. Hence, dietary natural products act as valuable tonic for different types of cancer. Studies also revealed that dietary natural products have potential to inhibit cancer by underlying various mechanisms such as inhibiting growth of cancer cells and metastasis and protecting against carcinogens.<sup><xref rid="bibr125-1559325818813227" ref-type="bibr">125</xref></sup> The anticancer potential of fruits, vegetables, spices, cereals, and edible macro-fungi and their bioactive constituents studied in various bioassay systems are given in <xref rid="table5-1559325818813227" ref-type="table">Table 5</xref>.</p><table-wrap id="table5-1559325818813227" orientation="portrait" position="float"><label>Table 5.</label><caption><p>Natural Compounds From Dietary Sources Used as a Source of Anticancer Agents.</p></caption><alternatives><graphic xlink:href="10.1177_1559325818813227-table5"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Serial Number</th><th rowspan="1" colspan="1">Dietary Natural Products</th><th rowspan="1" colspan="1">Bioactive Compounds</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td colspan="4" rowspan="1">Fruits</td></tr><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">Apples</td><td rowspan="1" colspan="1">Polyphenols</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr126-1559325818813227" ref-type="bibr">126</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">Mangosteen</td><td rowspan="1" colspan="1">&#x003b3;-Mangostin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr127-1559325818813227" ref-type="bibr">127</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Pomegranate</td><td rowspan="1" colspan="1">Alkaloids, anthocyanidins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr128-1559325818813227" ref-type="bibr">128</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">Sweetsop</td><td rowspan="1" colspan="1">Annonaceous acetogenins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr129-1559325818813227" ref-type="bibr">129</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">Berries</td><td rowspan="1" colspan="1">Resveratrol</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr130-1559325818813227" ref-type="bibr">130</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">Indian gooseberry</td><td rowspan="1" colspan="1">Tannins, flavonoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">Plum</td><td rowspan="1" colspan="1">Polyphenols</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr132-1559325818813227" ref-type="bibr">132</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">Grapes</td><td rowspan="1" colspan="1">Procyanidins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr133-1559325818813227" ref-type="bibr">133</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">9.</td><td rowspan="1" colspan="1">Apricot</td><td rowspan="1" colspan="1">Carotenoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr134-1559325818813227" ref-type="bibr">134</xref></sup>
</td></tr><tr><td colspan="4" rowspan="1">Vegetables</td></tr><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">Purple perilla</td><td rowspan="1" colspan="1">Rosmarinic acid, caffeic acid, apigenin, and isoegomake-tone</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr135-1559325818813227" ref-type="bibr">135</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">Bitter gourd</td><td rowspan="1" colspan="1">Lectin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr136-1559325818813227" ref-type="bibr">136</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Asparagus</td><td rowspan="1" colspan="1">Polysaccharides</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr137-1559325818813227" ref-type="bibr">137</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">Tomato</td><td rowspan="1" colspan="1">Lycopene and tomatine</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr138-1559325818813227" ref-type="bibr">138</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">Mungbean sprouts</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr139-1559325818813227" ref-type="bibr">139</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">French beans</td><td rowspan="1" colspan="1">Lectins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr140-1559325818813227" ref-type="bibr">140</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">Potato</td><td rowspan="1" colspan="1">Glycoalkaloids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr141-1559325818813227" ref-type="bibr">141</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">Celery</td><td rowspan="1" colspan="1">Pigenin, linamarose, vitamins A/C</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr142-1559325818813227" ref-type="bibr">142</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">9.</td><td rowspan="1" colspan="1">Cruciferous vegetables (radish, cauliflower, and broccoli)</td><td rowspan="1" colspan="1">Glucosinolates and isothiocyanates</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr143-1559325818813227" ref-type="bibr">143</xref></sup>
</td></tr><tr><td colspan="4" rowspan="1">Spices</td></tr><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">Turmeric</td><td rowspan="1" colspan="1">Curcumin, curcuma oil, aromatic tumerone, and sesquiterpenoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr144-1559325818813227" ref-type="bibr">144</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">Garlic</td><td rowspan="1" colspan="1">Organosulphur compounds (OSC), such as alliin, diallyl disulfide, allicin, and sodium 2-propenyl thiosulfate</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr145-1559325818813227" ref-type="bibr">145</xref>,<xref rid="bibr146-1559325818813227" ref-type="bibr">146</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Cinnamon</td><td rowspan="1" colspan="1">Isoobtusilactone A</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr129-1559325818813227" ref-type="bibr">129</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">Chili pepper</td><td rowspan="1" colspan="1">Capsaicin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr147-1559325818813227" ref-type="bibr">147</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">Ginger</td><td rowspan="1" colspan="1">Geraniol, pinostrobin, clavatol, gingeols, zingerone</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr148-1559325818813227" ref-type="bibr">148</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">Saffron</td><td rowspan="1" colspan="1">Carotenoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr149-1559325818813227" ref-type="bibr">149</xref></sup>
</td></tr><tr><td colspan="2" rowspan="1">Coffee</td><td rowspan="1" colspan="1">Caffeic acid (3,4-dihydroxycinnamic acid) and ferulic acid (4-hydroxy-3-methoxycinnamic acid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr150-1559325818813227" ref-type="bibr">150</xref></sup>
</td></tr><tr><td colspan="2" rowspan="1">Meat products</td><td rowspan="1" colspan="1">Conjugated linoleic acid (CLA)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr151-1559325818813227" ref-type="bibr">151</xref></sup>
</td></tr><tr><td colspan="2" rowspan="1">Green and black teas (<italic>Camellia sinensis</italic>)</td><td rowspan="1" colspan="1">Catechin and theaflavins</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr152-1559325818813227" ref-type="bibr">152</xref></sup>
</td></tr><tr><td colspan="4" rowspan="1">Cereals</td></tr><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">Rice bran</td><td rowspan="1" colspan="1">Peptide hydrolysates and phytic acid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr153-1559325818813227" ref-type="bibr">153</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">Corn silk</td><td rowspan="1" colspan="1">Polysaccharides</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr154-1559325818813227" ref-type="bibr">154</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">Oats, barley</td><td rowspan="1" colspan="1">&#x003b2;-Glucan</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr151-1559325818813227" ref-type="bibr">151</xref></sup>
</td></tr><tr><td colspan="4" rowspan="1">Edible macro-fungi</td></tr><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">
<italic>Pleurotus pulmonarius</italic>
</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr155-1559325818813227" ref-type="bibr">155</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">
<italic>Lentinula edodes</italic>
</td><td rowspan="1" colspan="1">Polysaccharide</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr156-1559325818813227" ref-type="bibr">156</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">
<italic>Agrocybe aegerita</italic>
</td><td rowspan="1" colspan="1">Lectin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr157-1559325818813227" ref-type="bibr">157</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">
<italic>Flammulina velutipes</italic>
</td><td rowspan="1" colspan="1">Glycoprotein</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr145-1559325818813227" ref-type="bibr">145</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">
<italic>Agaricus blazei</italic>
</td><td rowspan="1" colspan="1">&#x003b2;-glucan, blazeispirols A and C</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr158-1559325818813227" ref-type="bibr">158</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">
<italic>Grifola frondosa</italic>
</td><td rowspan="1" colspan="1">O-orsellinaldehyde</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr159-1559325818813227" ref-type="bibr">159</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">
<italic>Schizophyllum commune</italic>
</td><td rowspan="1" colspan="1">Schizophyllum</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr160-1559325818813227" ref-type="bibr">160</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">
<italic>Grifola frondosa</italic>
</td><td rowspan="1" colspan="1">Grifon D</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr160-1559325818813227" ref-type="bibr">160</xref></sup>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn2-1559325818813227"><p>Abbreviation: NA, not available.</p></fn></table-wrap-foot></table-wrap></sec><sec id="section50-1559325818813227"><title>Natural Products From Plants</title><p>Plants have been used in the treatment of cancer since many years. Natural products from plants specifically play an essential part in the improvement of treating various virally infected cancers (<xref rid="table6-1559325818813227" ref-type="table">Table 6</xref>). It is assessed that plant-derived compounds constitute more than half of anticancer agents.<sup><xref rid="bibr182-1559325818813227" ref-type="bibr">182</xref></sup>
</p><table-wrap id="table6-1559325818813227" orientation="portrait" position="float"><label>Table 6.</label><caption><p>Natural Compounds From Plants Used as a Source of Anticancer Agents.</p></caption><alternatives><graphic xlink:href="10.1177_1559325818813227-table6"/><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Serial Number</th><th rowspan="1" colspan="1">Plant Name</th><th rowspan="1" colspan="1">Family</th><th rowspan="1" colspan="1">Active Constituents</th><th rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1.</td><td rowspan="1" colspan="1">
<italic>Aegle marmelos</italic>
</td><td rowspan="1" colspan="1">Rutaceae</td><td rowspan="1" colspan="1">Lupeol (triterpene)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">2.</td><td rowspan="1" colspan="1">
<italic>Aglaia sylvestris</italic>
</td><td rowspan="1" colspan="1">Meliaceae</td><td rowspan="1" colspan="1">Silvestrol</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr161-1559325818813227" ref-type="bibr">161</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">3.</td><td rowspan="1" colspan="1">
<italic>Allium cepa</italic>
</td><td rowspan="1" colspan="1">Liliaceae</td><td rowspan="1" colspan="1">Allicin alliin, quercetin, flavonoids, vitamins C and E</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr133-1559325818813227" ref-type="bibr">133</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">4.</td><td rowspan="1" colspan="1">
<italic>Aloe barbadensis</italic>
</td><td rowspan="1" colspan="1">Liliaceae</td><td rowspan="1" colspan="1">Aloe-emodin, emodin, aloin acemannan</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr162-1559325818813227" ref-type="bibr">162</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">5.</td><td rowspan="1" colspan="1">
<italic>Alpinia galangagalangal</italic>
</td><td rowspan="1" colspan="1">Zingeberaceae</td><td rowspan="1" colspan="1">Acetoxy chavicol acetate, pinocembrin, galangin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">6.</td><td rowspan="1" colspan="1">
<italic>Angelica sinensis</italic>
</td><td rowspan="1" colspan="1">Umbelliferae</td><td rowspan="1" colspan="1">Carbohydrates</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr128-1559325818813227" ref-type="bibr">128</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">7.</td><td rowspan="1" colspan="1">
<italic>Apium graveolens</italic>
</td><td rowspan="1" colspan="1">Umbelliferae</td><td rowspan="1" colspan="1">Apigenin (flavonoid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr142-1559325818813227" ref-type="bibr">142</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">8.</td><td rowspan="1" colspan="1">
<italic>Artemisia monosperma</italic>
</td><td rowspan="1" colspan="1">Asteraceae</td><td rowspan="1" colspan="1">Capillin (1-phenyl-2,4-pentadiyne)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr163-1559325818813227" ref-type="bibr">163</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">9.</td><td rowspan="1" colspan="1">
<italic>Azadirecta indica</italic>
</td><td rowspan="1" colspan="1">Meliaceae</td><td rowspan="1" colspan="1">Triterpenoid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">10.</td><td rowspan="1" colspan="1">
<italic>Bauhinia variegata</italic>
</td><td rowspan="1" colspan="1">Caesalpinaceae</td><td rowspan="1" colspan="1">Glycosides, essential oil</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">11.</td><td rowspan="1" colspan="1">
<italic>Berberis vulgaris</italic>
</td><td rowspan="1" colspan="1">Berberidaceae</td><td rowspan="1" colspan="1">Berberine (an isoquinoline alkaloid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">12.</td><td rowspan="1" colspan="1">
<italic>Broussonetia papyrifera</italic>
</td><td rowspan="1" colspan="1">Urticaceae</td><td rowspan="1" colspan="1">Isolicoflavonol</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr164-1559325818813227" ref-type="bibr">164</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">13.</td><td rowspan="1" colspan="1">
<italic>Brucea antidysenterica</italic>
</td><td rowspan="1" colspan="1">Simaroubaceae</td><td rowspan="1" colspan="1">Bruceantin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr165-1559325818813227" ref-type="bibr">165</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">14.</td><td rowspan="1" colspan="1">
<italic>Camellia sinensis</italic>
</td><td rowspan="1" colspan="1">Theaceae</td><td rowspan="1" colspan="1">Catechin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr128-1559325818813227" ref-type="bibr">128</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">15.</td><td rowspan="1" colspan="1">
<italic>Campotheca acuminate</italic>
</td><td rowspan="1" colspan="1">Nyssaceae</td><td rowspan="1" colspan="1">Campothecin (alkaloid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr166-1559325818813227" ref-type="bibr">166</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">16.</td><td rowspan="1" colspan="1">
<italic>Catharanthus roseus</italic>
</td><td rowspan="1" colspan="1">Apocynaceae</td><td rowspan="1" colspan="1">Vinblastine, vincristine, and reserpine</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr166-1559325818813227" ref-type="bibr">166</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">17.</td><td rowspan="1" colspan="1">
<italic>Centaurea montata</italic>
</td><td rowspan="1" colspan="1">Asteraceae</td><td rowspan="1" colspan="1">Montamine (alkaloid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr128-1559325818813227" ref-type="bibr">128</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">18.</td><td rowspan="1" colspan="1">
<italic>Cephalotaxus harringtonia</italic>
</td><td rowspan="1" colspan="1">Cephalotaxaceae</td><td rowspan="1" colspan="1">Homoharringtonine (alkaloid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr166-1559325818813227" ref-type="bibr">166</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">19.</td><td rowspan="1" colspan="1">
<italic>Combretum caffrum</italic>
</td><td rowspan="1" colspan="1">Cobretaceae</td><td rowspan="1" colspan="1">Stilbenes, combretastatin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr167-1559325818813227" ref-type="bibr">167</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">20.</td><td rowspan="1" colspan="1">
<italic>Croton lechleri</italic>
</td><td rowspan="1" colspan="1">Euphorbiaceae</td><td rowspan="1" colspan="1">Taspine (alkaloid)</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr168-1559325818813227" ref-type="bibr">168</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">21.</td><td rowspan="1" colspan="1">
<italic>Erythroxylum pervillei</italic>
</td><td rowspan="1" colspan="1">Erythroxylaceae</td><td rowspan="1" colspan="1">Pervilleine A</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr169-1559325818813227" ref-type="bibr">169</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">22.</td><td rowspan="1" colspan="1">
<italic>Fagopyrum esculentum</italic>
</td><td rowspan="1" colspan="1">Polygonaceae</td><td rowspan="1" colspan="1">Tanins, flavonoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr128-1559325818813227" ref-type="bibr">128</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">23.</td><td rowspan="1" colspan="1">
<italic>Fragaria vesca</italic>
</td><td rowspan="1" colspan="1">Rosaceae</td><td rowspan="1" colspan="1">Tanins, flavonoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">24.</td><td rowspan="1" colspan="1">
<italic>Ginkgo biloba</italic>
</td><td rowspan="1" colspan="1">Ginkgoaceae</td><td rowspan="1" colspan="1">Ginkgolides B, A, C, and J</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr170-1559325818813227" ref-type="bibr">170</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">25.</td><td rowspan="1" colspan="1">
<italic>Glycyrrhiza glabra</italic>
</td><td rowspan="1" colspan="1">Leguminosae</td><td rowspan="1" colspan="1">Glycyrrhizin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr171-1559325818813227" ref-type="bibr">171</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">26.</td><td rowspan="1" colspan="1">
<italic>Gossypium barbadense</italic>
</td><td rowspan="1" colspan="1">Malvaceae</td><td rowspan="1" colspan="1">Gossypol</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr172-1559325818813227" ref-type="bibr">172</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">27.</td><td rowspan="1" colspan="1">
<italic>Indigofera tinctoria</italic>
</td><td rowspan="1" colspan="1">Leguminosae</td><td rowspan="1" colspan="1">Indigoids</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr166-1559325818813227" ref-type="bibr">166</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">28.</td><td rowspan="1" colspan="1">
<italic>Larrea tridentate</italic>
</td><td rowspan="1" colspan="1">Zygophyllaceae</td><td rowspan="1" colspan="1">Lignan</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr173-1559325818813227" ref-type="bibr">173</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">29.</td><td rowspan="1" colspan="1">
<italic>Lentinus edodes</italic>
</td><td rowspan="1" colspan="1">Agaricaceae</td><td rowspan="1" colspan="1">Lentinan</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr174-1559325818813227" ref-type="bibr">174</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">30.</td><td rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td rowspan="1" colspan="1">Ranunculaceae</td><td rowspan="1" colspan="1">Thymoquinone, dithymoquinone</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">31.</td><td rowspan="1" colspan="1">
<italic>Ocimum sanctum</italic>
</td><td rowspan="1" colspan="1">Lamiaceae</td><td rowspan="1" colspan="1">Eugenol, orientin, and vicenin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">32.</td><td rowspan="1" colspan="1">
<italic>Panax ginseng</italic>
</td><td rowspan="1" colspan="1">Aralaceae</td><td rowspan="1" colspan="1">Ginsenosides, panaxosides</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr175-1559325818813227" ref-type="bibr">175</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">33.</td><td rowspan="1" colspan="1">
<italic>Podophyllum peltatum</italic>
</td><td rowspan="1" colspan="1">Berberidaceae</td><td rowspan="1" colspan="1">Epipodophyllotoxin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr176-1559325818813227" ref-type="bibr">176</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">34.</td><td rowspan="1" colspan="1">
<italic>Prunella vulgaris</italic>
</td><td rowspan="1" colspan="1">Lamiaceae</td><td rowspan="1" colspan="1">Ursolic acid, oleanolic acid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">35.</td><td rowspan="1" colspan="1">
<italic>Psoralea corylifolia</italic>
</td><td rowspan="1" colspan="1">Fabaceae</td><td rowspan="1" colspan="1">Bavachinin and psoralen, psoralidin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">36.</td><td rowspan="1" colspan="1">
<italic>Pteris multifidi</italic>
</td><td rowspan="1" colspan="1">Pteridaceae</td><td rowspan="1" colspan="1">Terpenoid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr177-1559325818813227" ref-type="bibr">177</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">37.</td><td rowspan="1" colspan="1">
<italic>Saussurea lappa</italic>
</td><td rowspan="1" colspan="1">Compositae</td><td rowspan="1" colspan="1">Sesquiterpenes</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">38.</td><td rowspan="1" colspan="1">
<italic>Silybum marianum</italic>
</td><td rowspan="1" colspan="1">Asteraceae</td><td rowspan="1" colspan="1">Silymarin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr178-1559325818813227" ref-type="bibr">178</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">39.</td><td rowspan="1" colspan="1">
<italic>Solanum nigrum</italic>
</td><td rowspan="1" colspan="1">Solanaceae</td><td rowspan="1" colspan="1">Solamargine, solasonine, solanin, quercetin</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr128-1559325818813227" ref-type="bibr">128</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">40.</td><td rowspan="1" colspan="1">
<italic>Taxus brevifolia</italic>
</td><td rowspan="1" colspan="1">Taxaceae</td><td rowspan="1" colspan="1">Taxanes, taxol cepholomannine</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr179-1559325818813227" ref-type="bibr">179</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">41.</td><td rowspan="1" colspan="1">
<italic>Tinospora cardifolia</italic>
</td><td rowspan="1" colspan="1">Menispermaceae</td><td rowspan="1" colspan="1">Sesquiterpenes, diterpenes</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr131-1559325818813227" ref-type="bibr">131</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">42.</td><td rowspan="1" colspan="1">
<italic>Vitex rotundifolia</italic>
</td><td rowspan="1" colspan="1">Verbenaceae</td><td rowspan="1" colspan="1">Flavonoid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr180-1559325818813227" ref-type="bibr">180</xref></sup>
</td></tr><tr><td rowspan="1" colspan="1">43.</td><td rowspan="1" colspan="1">
<italic>Ziziphus mauritiana</italic>
</td><td rowspan="1" colspan="1">Rhamnaceae</td><td rowspan="1" colspan="1">Betulinic acid</td><td rowspan="1" colspan="1">
<sup><xref rid="bibr181-1559325818813227" ref-type="bibr">181</xref></sup>
</td></tr></tbody></table></alternatives></table-wrap></sec></sec><sec id="section51-1559325818813227"><title>Future Perspective</title><p>Tumor virology in humans has achieved great attention since past 100 years. Viruses have adopted a lot of approaches for hijacking host cellular pathways that are mandatory for carcinogenesis. Infection-associated tumors remained an eminent problem globally. Immune system of body normally inhibits the growth of tumor cells that require the expression of viral proteins for their survival, or sometimes curb the viral replication, thus reducing the likelihood of a &#x0201c;oncogenic hit.&#x0201d; So, all human cancers, mostly progresses in case of immunosuppression and the protective effect of immune system, play a central role in carcinogenesis.</p><p>With the advent of technologies, it is important to find out different techniques for cancer treatment and its prevention. Nature has remained a prime source of medicinal products for centuries. Secondary metabolites present in the microbes and marine organisms serve as a new frontier for discovery of natural products used for the treatment of virally infected cancers. The culturing of the respective microorganism may for the most part be a practical way to increase quantities. Moreover, with the incredible advancements of pharmaceutical industries, medicinal plants offer major resource for the development of potential novel agents. Compounds isolated from the plants have potential to effectively target the tumor cells and avoid their harmful effects on normal healthy tissues. Besides all, tobacco smoking and imperfect diet also result in carcinogenesis. So, cancer development can also be mitigated by consumption of proper and adequate diet.</p><p>Overall studies revealed that these natural products isolated from various insects, marine, and microorganisms as well as medicinal plants are useful in protecting virally infected cancer. Moreover, consuming a diet rich in antioxidant fruits, vegetables, herbs, and so on, also provides health-protective effects. Cancer is one of major problem in both developing and developed countries. Chemotherapy and radiation therapy causes various side effects; therefore, there is requirement of an alternative medicine to treat cancer. Nature possesses great chemical diversity that provides one of the most efficient sources of inspiration for medicinal and drug discovery chemists. Natural products can be recommended to the rural and poor people to treat effectively the cancers as they are cheaper; beside this, they can be used in developing drugs as they have no side effects. So, the data analyzed in this study have provided us with information that can provide basis for the future pharmacological screening, leading to natural drugs discovery development. Various bioactive compounds can be isolated and identified easily from natural products extracts via advance techniques. Moreover, in future, attention should be paid on the role of various molecules involved in carcinogenesis and further detailed pharmacological and in vivo studies are required for large-scale implementation of drugs for cancer chemoprevention.</p></sec></body><back><fn-group><fn fn-type="COI-statement" id="fn1-1559325818813227"><p><bold>Declaration of Conflicting Interests:</bold> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure" id="fn2-1559325818813227"><p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-1559325818813227"><label>1</label><mixed-citation publication-type="book">
<collab collab-type="author">World Health Organization</collab>. <source>National Cancer Control Programmes: Policies and Managerial Guidelines</source>. <publisher-loc>WHO</publisher-loc>: <publisher-name>Geneva; 2002</publisher-name>.</mixed-citation></ref><ref id="bibr2-1559325818813227"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bouvard</surname><given-names>V</given-names></name><name><surname>Baan</surname><given-names>R</given-names></name><name><surname>Straif</surname><given-names>K</given-names></name><etal/></person-group>; <article-title>WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens&#x02014;part B: biological agents</article-title>. <source>Lancet Oncol</source>. <year>2009</year>;<volume>10</volume>(<issue>4</issue>):<fpage>321</fpage>&#x02013;<lpage>322</lpage>.<pub-id pub-id-type="pmid">19350698</pub-id></mixed-citation></ref><ref id="bibr3-1559325818813227"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soares</surname><given-names>JP</given-names></name><name><surname>Cortinhas</surname><given-names>A</given-names></name><name><surname>Bento</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Aging and DNA damage in humans: a meta-analysis study</article-title>. <source>Aging</source>. <year>2014</year>;<volume>6</volume>(<issue>6</issue>):<fpage>432</fpage>&#x02013;<lpage>439</lpage>.<pub-id pub-id-type="pmid">25140379</pub-id></mixed-citation></ref><ref id="bibr4-1559325818813227"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lombard</surname><given-names>DB</given-names></name><name><surname>Chua</surname><given-names>KF</given-names></name><name><surname>Mostoslavsky</surname><given-names>R</given-names></name><name><surname>Franco</surname><given-names>S</given-names></name><name><surname>Gostissa</surname><given-names>M</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name></person-group>
<article-title>DNA repair, genome stability and aging</article-title>. <source>Cell</source>. <year>2005</year>;<volume>120</volume>(<issue>4</issue>):<fpage>497</fpage>&#x02013;<lpage>512</lpage>.<pub-id pub-id-type="pmid">15734682</pub-id></mixed-citation></ref><ref id="bibr5-1559325818813227"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moore</surname><given-names>PS</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name></person-group>
<article-title>Why do viruses cause cancer? Highlights of the first century of human tumour virology</article-title>. <source>Nat Rev Cancer</source>. <year>2010</year>;<volume>10</volume>(<issue>12</issue>):<fpage>878</fpage>&#x02013;<lpage>889</lpage>.<pub-id pub-id-type="pmid">21102637</pub-id></mixed-citation></ref><ref id="bibr6-1559325818813227"><label>6</label><mixed-citation publication-type="web">
<collab collab-type="author"><italic>IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Biological Agents Vol. 100B</italic></collab>. <article-title>World Health Organization</article-title>. <comment>2012</comment>
<ext-link ext-link-type="uri" xlink:href="http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf">http://monographs.iarc.fr/ENG/Monographs/vol100B/mono100B.pdf</ext-link>.</mixed-citation></ref><ref id="bibr7-1559325818813227"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Young</surname><given-names>LS</given-names></name><name><surname>Rickinson</surname><given-names>AB</given-names></name></person-group>
<article-title>Epstein-Barr virus: 40 years on</article-title>. <source>Nat Rev Cancer</source>. <year>2004</year>;<volume>4</volume>(<issue>10</issue>):<fpage>757</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">15510157</pub-id></mixed-citation></ref><ref id="bibr8-1559325818813227"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mesri</surname><given-names>EA</given-names></name><name><surname>Cesarman</surname><given-names>E</given-names></name><name><surname>Boshoff</surname><given-names>C</given-names></name></person-group>
<article-title>Kaposi&#x02019;s sarcoma and its associated herpesvirus</article-title>. <source>Nat Rev Cancer</source>. <year>2010</year>;<volume>10</volume>(<issue>10</issue>):<fpage>707</fpage>&#x02013;<lpage>719</lpage>.<pub-id pub-id-type="pmid">20865011</pub-id></mixed-citation></ref><ref id="bibr9-1559325818813227"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Woodman</surname><given-names>CB</given-names></name><name><surname>Collins</surname><given-names>SI</given-names></name><name><surname>Young</surname><given-names>LS</given-names></name></person-group>
<article-title>The natural history of cervical HPV infection: unresolved issues</article-title>. <source>Nat Rev Cancer</source>. <year>2007</year>;<volume>7</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">17186016</pub-id></mixed-citation></ref><ref id="bibr10-1559325818813227"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doorbar</surname><given-names>J</given-names></name></person-group>
<article-title>Molecular biology of human papillomavirus infection and cervical cancer</article-title>. <source>Clin Sci (Lond)</source>. <year>2006</year>;<volume>110</volume>(<issue>5</issue>):<fpage>525</fpage>&#x02013;<lpage>541</lpage>.<pub-id pub-id-type="pmid">16597322</pub-id></mixed-citation></ref><ref id="bibr11-1559325818813227"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>PS</given-names></name></person-group>
<article-title>Merkel cell carcinoma: a virus induced human cancer</article-title>. <source>Annu Rev Pathol</source>. <year>2012</year>;<volume>7</volume>:<fpage>123</fpage>&#x02013;<lpage>144</lpage>.<pub-id pub-id-type="pmid">21942528</pub-id></mixed-citation></ref><ref id="bibr12-1559325818813227"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seeger</surname><given-names>C</given-names></name><name><surname>Mason</surname><given-names>WS</given-names></name></person-group>
<article-title>Hepatitis B virus biology</article-title>. <source>Microbiol Mol Biol Rev</source>. <year>2000</year>;<volume>64</volume>(<issue>1</issue>):<fpage>51</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">10704474</pub-id></mixed-citation></ref><ref id="bibr13-1559325818813227"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Scheel</surname><given-names>TK</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name></person-group>
<article-title>Understanding the hepatitis C virus life cycle paves the way for highly effective therapies</article-title>. <source>Nat Med</source>. <year>2013</year>;<volume>19</volume>(<issue>7</issue>):<fpage>837</fpage>&#x02013;<lpage>849</lpage>.<pub-id pub-id-type="pmid">23836234</pub-id></mixed-citation></ref><ref id="bibr14-1559325818813227"><label>14</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kannian</surname><given-names>P</given-names></name><name><surname>Green</surname><given-names>PL</given-names></name></person-group>
<article-title>Human T lymphotropic virus type 1 (HTLV-1): molecular biology and oncogenesis</article-title>. <source>Viruses</source>. <year>2010</year>;<volume>2</volume>(<issue>9</issue>):<fpage>2037</fpage>&#x02013;<lpage>2077</lpage>.<pub-id pub-id-type="pmid">21994719</pub-id></mixed-citation></ref><ref id="bibr15-1559325818813227"><label>15</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stevenson</surname><given-names>M</given-names></name></person-group>
<article-title>HIV-1 pathogenesis</article-title>. <source>Nat Med</source>. <year>2003</year>;<volume>9</volume>(<issue>7</issue>):<fpage>853</fpage>&#x02013;<lpage>860</lpage>.<pub-id pub-id-type="pmid">12835705</pub-id></mixed-citation></ref><ref id="bibr16-1559325818813227"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Epstein</surname><given-names>MA</given-names></name><name><surname>Achong</surname><given-names>BG</given-names></name><name><surname>Barr</surname><given-names>YM</given-names></name></person-group>
<article-title>Virus particles in cultured lymphoblasts from Burkitt&#x02019;s lymphoma</article-title>. <source>Lancet</source>. <year>1964</year>;<volume>1</volume>(<issue>7335</issue>):<fpage>702</fpage>&#x02013;<lpage>703</lpage>.<pub-id pub-id-type="pmid">14107961</pub-id></mixed-citation></ref><ref id="bibr17-1559325818813227"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Klein</surname><given-names>G</given-names></name><name><surname>Klein</surname><given-names>E</given-names></name><name><surname>Kashuba</surname><given-names>E</given-names></name></person-group>
<article-title>Interaction of Epstein-Barr virus (EBV) with human B lymphocytes</article-title>. <source>Biochem Biophy Res Commun</source>. <year>2010</year>;<volume>396</volume>(<issue>1</issue>):<fpage>67</fpage>&#x02013;<lpage>73</lpage>.</mixed-citation></ref><ref id="bibr18-1559325818813227"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerber</surname><given-names>P</given-names></name><name><surname>Walsh</surname><given-names>JH</given-names></name><name><surname>Rosenblum</surname><given-names>EN</given-names></name><etal/></person-group>
<article-title>Association of EB-virus infection with the post-perfusion syndrome</article-title>. <source>Lancet</source>. <year>1969</year>;<volume>1</volume>(<issue>7595</issue>):<fpage>593</fpage>&#x02013;<lpage>595</lpage>.<pub-id pub-id-type="pmid">4180127</pub-id></mixed-citation></ref><ref id="bibr19-1559325818813227"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stock</surname><given-names>I</given-names></name></person-group>
<article-title>Infectious mononucleosis&#x02014;a &#x0201c;childhood disease&#x0201d; of great medical concern</article-title>. <source>Med Monatsschr Pharm</source>. <year>2013</year>;<volume>36</volume>(<issue>10</issue>):<fpage>364</fpage>&#x02013;<lpage>368</lpage>.<pub-id pub-id-type="pmid">24266247</pub-id></mixed-citation></ref><ref id="bibr20-1559325818813227"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shair</surname><given-names>KH</given-names></name><name><surname>Schnegg</surname><given-names>CI</given-names></name><name><surname>Raab-Traub</surname><given-names>N</given-names></name></person-group>
<article-title>EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration</article-title>. <source>Cancer Res</source>. <year>2008</year>;<volume>68</volume>(<issue>17</issue>):<fpage>6997</fpage>&#x02013;<lpage>7005</lpage>.<pub-id pub-id-type="pmid">18757414</pub-id></mixed-citation></ref><ref id="bibr21-1559325818813227"><label>21</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Rickinson</surname><given-names>AB</given-names></name><name><surname>Kieff</surname><given-names>E</given-names></name></person-group>
<source>Epstein-Barr Virus. In Fields Virology</source>. Vol. <volume>2</volume>
<publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott-Raven Publishers</publisher-name>; <year>1996</year>:<fpage>2397</fpage>&#x02013;<lpage>2446</lpage>.</mixed-citation></ref><ref id="bibr22-1559325818813227"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cai</surname><given-names>Q</given-names></name><name><surname>Verma</surname><given-names>SC</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Robertson</surname><given-names>ES</given-names></name></person-group>
<article-title>Molecular biology of Kaposi&#x02019;s sarcoma-associated herpesvirus and related oncogenesis</article-title>. <source>Adv Virus Res</source>. <year>2010</year>;<volume>78</volume>:<fpage>87</fpage>&#x02013;<lpage>142</lpage>.<pub-id pub-id-type="pmid">21040832</pub-id></mixed-citation></ref><ref id="bibr23-1559325818813227"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schiffman</surname><given-names>M</given-names></name><name><surname>Castle</surname><given-names>PE</given-names></name><name><surname>Jeronimo</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Human papillomavirus and cervical cancer</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>370</volume>(<issue>9580</issue>):<fpage>890</fpage>&#x02013;<lpage>907</lpage>.<pub-id pub-id-type="pmid">17826171</pub-id></mixed-citation></ref><ref id="bibr24-1559325818813227"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moens</surname><given-names>U</given-names></name><name><surname>Van Ghelue</surname><given-names>M</given-names></name><name><surname>Johannessen</surname><given-names>M</given-names></name></person-group>
<article-title>Oncogenic potentials of the human polyomavirus regulatory proteins</article-title>. <source>Cell Mol Life Sci</source>. <year>2007</year>;<volume>64</volume>(<issue>13</issue>):<fpage>1656</fpage>&#x02013;<lpage>1678</lpage>.<pub-id pub-id-type="pmid">17483871</pub-id></mixed-citation></ref><ref id="bibr25-1559325818813227"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kew</surname><given-names>MC</given-names></name></person-group>
<article-title>Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma</article-title>. <source>Pathol Biol</source>. <year>2010</year>;<volume>58</volume>(<issue>4</issue>):<fpage>273</fpage>&#x02013;<lpage>277</lpage>.<pub-id pub-id-type="pmid">20378277</pub-id></mixed-citation></ref><ref id="bibr26-1559325818813227"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tarocchi</surname><given-names>M</given-names></name><name><surname>Polvani</surname><given-names>S</given-names></name><name><surname>Marroncini</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Molecular mechanism of hepatitis B virus induced hepatocarcinogenesis</article-title>. <source>World J Gastroenterol</source>. <year>2014</year>;<volume>20</volume>(<issue>33</issue>):<fpage>11630</fpage>&#x02013;<lpage>11640</lpage>.<pub-id pub-id-type="pmid">25206269</pub-id></mixed-citation></ref><ref id="bibr27-1559325818813227"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tang</surname><given-names>H</given-names></name><name><surname>Grise</surname><given-names>H</given-names></name></person-group>
<article-title>Cellular and molecular biology of HCV infection and hepatitis</article-title>. <source>Clin Sci</source>. <year>2009</year>;<volume>117</volume>(<issue>2</issue>):<fpage>49</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">19515018</pub-id></mixed-citation></ref><ref id="bibr28-1559325818813227"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>RL</given-names></name><name><surname>Baack</surname><given-names>B</given-names></name><name><surname>Smith</surname><given-names>BD</given-names></name><etal/></person-group>
<article-title>Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies</article-title>. <source>Ann Intern Med</source>. <year>2013</year>;<volume>158</volume>(<issue>5 pt 1</issue>):<fpage>329</fpage>&#x02013;<lpage>337</lpage>.<pub-id pub-id-type="pmid">23460056</pub-id></mixed-citation></ref><ref id="bibr29-1559325818813227"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moriya</surname><given-names>K</given-names></name><name><surname>Yotsuyanagi</surname><given-names>H</given-names></name><name><surname>Shintani</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Hepatitis C virus core protein induces hepatic steatosis in transgenic mice</article-title>. <source>J Gen Virol</source>. <year>1997</year>;<volume>78</volume>(<issue>pt 7</issue>):<fpage>1527</fpage>&#x02013;<lpage>1531</lpage>.<pub-id pub-id-type="pmid">9225025</pub-id></mixed-citation></ref><ref id="bibr30-1559325818813227"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boxus</surname><given-names>M</given-names></name><name><surname>Willems</surname><given-names>L</given-names></name></person-group>
<article-title>Mechanisms of HTLV-1 persistence and transformation</article-title>. <source>Br J Cancer</source>. <year>2009</year>;<volume>101</volume>(<issue>9</issue>):<fpage>1497</fpage>&#x02013;<lpage>1501</lpage>.<pub-id pub-id-type="pmid">19861996</pub-id></mixed-citation></ref><ref id="bibr31-1559325818813227"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Takaoka</surname><given-names>A</given-names></name><name><surname>Hayakawa</surname><given-names>S</given-names></name><name><surname>Yanai</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Integration of interferon-&#x003b1;/&#x003b2; signalling to p53 responses in tumour suppression and antiviral defence</article-title>. <source>Nature</source>. <year>2003</year>;<volume>424</volume>(<issue>6948</issue>):<fpage>516</fpage>&#x02013;<lpage>523</lpage>.<pub-id pub-id-type="pmid">12872134</pub-id></mixed-citation></ref><ref id="bibr32-1559325818813227"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sadler</surname><given-names>AJ</given-names></name><name><surname>Williams</surname><given-names>BR</given-names></name></person-group>
<article-title>Interferon-inducible antiviral effectors</article-title>. <source>Nat Rev Immunol</source>. <year>2008</year>;<volume>8</volume>(<issue>7</issue>):<fpage>559</fpage>&#x02013;<lpage>568</lpage>.<pub-id pub-id-type="pmid">18575461</pub-id></mixed-citation></ref><ref id="bibr33-1559325818813227"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>HR</given-names></name><name><surname>Kim</surname><given-names>MH</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Jung</surname><given-names>JU</given-names></name></person-group>
<article-title>Viral interferon regulatory factors</article-title>. <source>J Interferon Cytokine Res</source>. <year>2009</year>;<volume>29</volume>(<issue>9</issue>):<fpage>621</fpage>&#x02013;<lpage>627</lpage>.<pub-id pub-id-type="pmid">19715458</pub-id></mixed-citation></ref><ref id="bibr34-1559325818813227"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>M</given-names></name><name><surname>Osborne</surname><given-names>J</given-names></name><name><surname>Bestetti</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>PS</given-names></name></person-group>
<article-title>Viral IL-6-induced cell proliferation and immune evasion of interferon activity</article-title>. <source>Science</source>. <year>2002</year>;<volume>298</volume>(<issue>5597</issue>):<fpage>1432</fpage>&#x02013;<lpage>1435</lpage>.<pub-id pub-id-type="pmid">12434062</pub-id></mixed-citation></ref><ref id="bibr35-1559325818813227"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cloutier</surname><given-names>N</given-names></name><name><surname>Flamand</surname><given-names>L</given-names></name></person-group>
<article-title>Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) &#x003b2; expression by competing with IFN regulatory factor-3 for binding to IFNB promoter</article-title>. <source>J Biol Chem</source>. <year>2010</year>;<volume>285</volume>(<issue>10</issue>):<fpage>7208</fpage>&#x02013;<lpage>7221</lpage>.<pub-id pub-id-type="pmid">20048166</pub-id></mixed-citation></ref><ref id="bibr36-1559325818813227"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wies</surname><given-names>E</given-names></name><name><surname>Hahn</surname><given-names>AS</given-names></name><name><surname>Schmidt</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>The Kaposi&#x02019;s sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5</article-title>. <source>J Biol Chem</source>. <year>2009</year>;<volume>284</volume>(<issue>13</issue>):<fpage>8525</fpage>&#x02013;<lpage>8538</lpage>.<pub-id pub-id-type="pmid">19129183</pub-id></mixed-citation></ref><ref id="bibr37-1559325818813227"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Engels</surname><given-names>EA</given-names></name><name><surname>Frisch</surname><given-names>M</given-names></name><name><surname>Goedert</surname><given-names>JJ</given-names></name><name><surname>Biggar</surname><given-names>RJ</given-names></name><name><surname>Miller</surname><given-names>RW</given-names></name></person-group>
<article-title>Merkel cell carcinoma and HIV infection</article-title>. <source>Lancet</source>. <year>2002</year>;<volume>359</volume>(<issue>9305</issue>):<fpage>497</fpage>&#x02013;<lpage>498</lpage>.<pub-id pub-id-type="pmid">11853800</pub-id></mixed-citation></ref><ref id="bibr38-1559325818813227"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harris</surname><given-names>TG</given-names></name><name><surname>Burk</surname><given-names>RD</given-names></name><name><surname>Palefsky</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results</article-title>. <source>JAMA</source>. <year>2005</year>;<volume>293</volume>(<issue>12</issue>):<fpage>1471</fpage>&#x02013;<lpage>1476</lpage>.<pub-id pub-id-type="pmid">15784870</pub-id></mixed-citation></ref><ref id="bibr39-1559325818813227"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frisch</surname><given-names>M</given-names></name><name><surname>Biggar</surname><given-names>RJ</given-names></name><name><surname>Goedert</surname><given-names>JJ</given-names></name></person-group>
<article-title>Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome</article-title>. <source>J Natl Cancer Inst</source>. <year>2000</year>;<volume>92</volume>:<fpage>1500</fpage>&#x02013;<lpage>1510</lpage>.<pub-id pub-id-type="pmid">10995805</pub-id></mixed-citation></ref><ref id="bibr40-1559325818813227"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawano</surname><given-names>N</given-names></name><name><surname>Shimoda</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation</article-title>. <source>Transplantation</source>. <year>2006</year>;<volume>82</volume>(<issue>6</issue>):<fpage>840</fpage>&#x02013;<lpage>843</lpage>.<pub-id pub-id-type="pmid">17006333</pub-id></mixed-citation></ref><ref id="bibr41-1559325818813227"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reddy</surname><given-names>L</given-names></name><name><surname>Odhava</surname><given-names>B</given-names></name><name><surname>Bhool</surname><given-names>KD</given-names></name></person-group>
<article-title>Natural products for cancer prevention: a global perspective</article-title>. <source>Pharmacol Ther</source>. <year>2003</year>;<volume>99</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">12804695</pub-id></mixed-citation></ref><ref id="bibr42-1559325818813227"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khidr</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>PL</given-names></name></person-group>
<article-title>RB, the conductor that orchestrates life, death and differentiation</article-title>. <source>Oncogene</source>. <year>2006</year>;<volume>25</volume>(<issue>38</issue>):<fpage>5210</fpage>&#x02013;<lpage>5219</lpage>.<pub-id pub-id-type="pmid">16936739</pub-id></mixed-citation></ref><ref id="bibr43-1559325818813227"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friborg</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>W</given-names></name><name><surname>Hottiger</surname><given-names>MO</given-names></name><etal/></person-group>
<article-title>p53 inhibition by the LANA protein of KSHV protects against cell death</article-title>. <source>Nature</source>. <year>1999</year>;<volume>402</volume>(<issue>6764</issue>):<fpage>889</fpage>&#x02013;<lpage>894</lpage>.<pub-id pub-id-type="pmid">10622254</pub-id></mixed-citation></ref><ref id="bibr44-1559325818813227"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Golubkov</surname><given-names>VS</given-names></name><name><surname>Strongin</surname><given-names>AY</given-names></name><etal/></person-group>
<article-title>Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>5</issue>):<fpage>2793</fpage>&#x02013;<lpage>2803</lpage>.<pub-id pub-id-type="pmid">18032378</pub-id></mixed-citation></ref><ref id="bibr45-1559325818813227"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>SB</given-names></name><name><surname>Graham</surname><given-names>ME</given-names></name><name><surname>Lovrecz</surname><given-names>GO</given-names></name><name><surname>Bache</surname><given-names>N</given-names></name><name><surname>Robinson</surname><given-names>PJ</given-names></name><name><surname>Reddel</surname><given-names>RR</given-names></name></person-group>
<article-title>Protein composition of catalytically active human telomerase from immortal cells</article-title>. <source>Science</source>. <year>2007</year>;<volume>315</volume>(<issue>5820</issue>):<fpage>1850</fpage>&#x02013;<lpage>1853</lpage>.<pub-id pub-id-type="pmid">17395830</pub-id></mixed-citation></ref><ref id="bibr46-1559325818813227"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terrin</surname><given-names>L</given-names></name><name><surname>Dal Col</surname><given-names>J</given-names></name><name><surname>Rampazzo</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Latent membrane protein 1 of Epstein-Barr virus activates the HTERT promoter and enhances telomerase activity in B lymphocytes</article-title>. <source>J Virol</source>. <year>2008</year>;<volume>82</volume>(<issue>20</issue>):<fpage>10175</fpage>&#x02013;<lpage>10187</lpage>.<pub-id pub-id-type="pmid">18684838</pub-id></mixed-citation></ref><ref id="bibr47-1559325818813227"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohashi</surname><given-names>M</given-names></name><name><surname>Sakurai</surname><given-names>M</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Human T-cell leukemia virus type 1 Tax oncoprotein induces and interacts with a multi-PDZ domain protein, MAGI-3</article-title>. <source>Virology</source>. <year>2004</year>;<volume>320</volume>(<issue>1</issue>):<fpage>52</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">15003862</pub-id></mixed-citation></ref><ref id="bibr48-1559325818813227"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lewis</surname><given-names>BP</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name><name><surname>Bartel</surname><given-names>DP</given-names></name></person-group>
<article-title>Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets</article-title>. <source>Cell</source>. <year>2005</year>;<volume>120</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">15652477</pub-id></mixed-citation></ref><ref id="bibr49-1559325818813227"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calin</surname><given-names>GA</given-names></name><name><surname>Croce</surname><given-names>CM</given-names></name></person-group>
<article-title>MicroRNA signatures in human cancers</article-title>. <source>Nat Rev Cancer</source>. <year>2006</year>;<volume>6</volume>(<issue>11</issue>):<fpage>857</fpage>&#x02013;<lpage>866</lpage>.<pub-id pub-id-type="pmid">17060945</pub-id></mixed-citation></ref><ref id="bibr50-1559325818813227"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Schafer</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed</article-title>. <source>PLoS Pathog</source>. <year>2006</year>;<volume>2</volume>(<issue>3</issue>):<fpage>e23</fpage>.<pub-id pub-id-type="pmid">16557291</pub-id></mixed-citation></ref><ref id="bibr51-1559325818813227"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marquitz</surname><given-names>AR</given-names></name><name><surname>Raab-Traub</surname><given-names>N</given-names></name></person-group>
<article-title>The role of miRNAs and EBV Barts in NPC</article-title>. <source>Semin Cancer Biol</source>. <year>2012</year>;<volume>22</volume>(<issue>2</issue>):<fpage>166</fpage>&#x02013;<lpage>172</lpage>.<pub-id pub-id-type="pmid">22178394</pub-id></mixed-citation></ref><ref id="bibr52-1559325818813227"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chimal-Ramirez</surname><given-names>GK</given-names></name><name><surname>Espinoza-Sanchez</surname><given-names>NA</given-names></name><name><surname>Fuentes-Panana</surname><given-names>EM</given-names></name></person-group>
<article-title>Protumor activities of the immune response: insights in the mechanisms of immunological shift, oncotraining, and oncopromotion</article-title>. <source>J Oncol</source>. <year>2013</year>:<fpage>835</fpage>&#x02013;<lpage>956</lpage>.</mixed-citation></ref><ref id="bibr53-1559325818813227"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chadburn</surname><given-names>A</given-names></name><name><surname>Abdul-Nabi</surname><given-names>AM</given-names></name><name><surname>Teruya</surname><given-names>BS</given-names></name><name><surname>Lo</surname><given-names>AA</given-names></name></person-group>
<article-title>Lymphoid proliferations associated with human immunodeficiency virus infection</article-title>. <source>Arch Pathol Lab Med</source>. <year>2013</year>;<volume>137</volume>(<issue>3</issue>):<fpage>360</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">23451747</pub-id></mixed-citation></ref><ref id="bibr54-1559325818813227"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Michaelis</surname><given-names>M</given-names></name><name><surname>Doerr</surname><given-names>HW</given-names></name><name><surname>Cinatl</surname><given-names>J</given-names></name></person-group>
<article-title>The story of human cytomegalovirus and cancer: increasing evidence and open questions</article-title>. <source>Neoplasia</source>. <year>2009</year>;<volume>11</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19107226</pub-id></mixed-citation></ref><ref id="bibr55-1559325818813227"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Orange</surname><given-names>JS</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name></person-group>
<article-title>Characterization of early IL-12, IFN-&#x003b1;/&#x003b2;, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection</article-title>. <source>J Immunol</source>. <year>1996</year>;<volume>156</volume>(<issue>12</issue>):<fpage>4746</fpage>&#x02013;<lpage>4756</lpage>.<pub-id pub-id-type="pmid">8648121</pub-id></mixed-citation></ref><ref id="bibr56-1559325818813227"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Diefenbach</surname><given-names>A</given-names></name><name><surname>Schindler</surname><given-names>H</given-names></name><name><surname>Donhauser</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Type 1 interferon IFN-&#x003b1;/&#x003b2; and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite</article-title>. <source>Immunity</source>. <year>1998</year>;<volume>8</volume>(<issue>1</issue>):<fpage>77</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">9462513</pub-id></mixed-citation></ref><ref id="bibr57-1559325818813227"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name><name><surname>Borrow</surname><given-names>P</given-names></name><name><surname>Sprent</surname><given-names>J</given-names></name></person-group>
<article-title>Induction of bystander T cell proliferation by viruses and type I interferon in vivo</article-title>. <source>Science</source>. <year>1996</year>;<volume>272</volume>(<issue>5270</issue>):<fpage>1947</fpage>&#x02013;<lpage>1950</lpage>.<pub-id pub-id-type="pmid">8658169</pub-id></mixed-citation></ref><ref id="bibr58-1559325818813227"><label>58</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Vilcek</surname><given-names>J</given-names></name><name><surname>Sen</surname><given-names>GC</given-names></name></person-group>
<chapter-title>Interferons and other cytokines</chapter-title> In: <person-group person-group-type="editor"><name><surname>Bernard</surname><given-names>N</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Howley</surname><given-names>PM</given-names></name></person-group>, eds. <source>Fundamental Virology Fields</source>. <edition>3rd ed</edition>
<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Lippincott-Raven Publishers</publisher-name>; <year>1996</year>:<fpage>341</fpage>&#x02013;<lpage>365</lpage>.</mixed-citation></ref><ref id="bibr59-1559325818813227"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruzek</surname><given-names>MC</given-names></name><name><surname>Miller</surname><given-names>AH</given-names></name><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>Pearce</surname><given-names>BD</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name></person-group>
<article-title>Characterization of early cytokine responses and an interleukin-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection</article-title>. <source>J Exp Med</source>. <year>1997</year>;<volume>185</volume>(<issue>7</issue>):<fpage>1185</fpage>&#x02013;<lpage>1192</lpage>.<pub-id pub-id-type="pmid">9104805</pub-id></mixed-citation></ref><ref id="bibr60-1559325818813227"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>QW</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name></person-group>
<article-title>Nitric oxide and macrophage function</article-title>. <source>Annu Rev Immunol</source>. <year>1997</year>;<volume>15</volume>:<fpage>323</fpage>&#x02013;<lpage>350</lpage>.<pub-id pub-id-type="pmid">9143691</pub-id></mixed-citation></ref><ref id="bibr61-1559325818813227"><label>61</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Guidotti</surname><given-names>LG</given-names></name><name><surname>Chisari</surname><given-names>FV</given-names></name></person-group>
<chapter-title>To kill or to cure: options in host defense against viral infection</chapter-title> In: <person-group person-group-type="editor"><name><surname>Zinkernagel</surname><given-names>R</given-names></name><name><surname>Bloom</surname><given-names>B</given-names></name></person-group>, eds. <source>Current Opinion in Immunology</source>. <publisher-loc>London, England</publisher-loc>: <publisher-name>Current Biology, Ltd</publisher-name>; <year>1996</year>:<fpage>478</fpage>&#x02013;<lpage>483</lpage>.</mixed-citation></ref><ref id="bibr62-1559325818813227"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Victoria</surname><given-names>JC</given-names></name><name><surname>Luca</surname><given-names>GG</given-names></name><name><surname>Francis</surname><given-names>VC</given-names></name></person-group>
<article-title>Interleukin-12 inhibits hepatitis B virus replication in transgenic mice</article-title>. <source>J Virol</source>. <year>1997</year>;<volume>71</volume>(<issue>4</issue>):<fpage>3236</fpage>&#x02013;<lpage>3243</lpage>.<pub-id pub-id-type="pmid">9060687</pub-id></mixed-citation></ref><ref id="bibr63-1559325818813227"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koutsoudakis</surname><given-names>G</given-names></name><name><surname>Kaul</surname><given-names>A</given-names></name><name><surname>Steinmann</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses</article-title>. <source>J Virol</source>. <year>2006</year>;<volume>80</volume>(<issue>11</issue>):<fpage>5308</fpage>&#x02013;<lpage>5320</lpage>.<pub-id pub-id-type="pmid">16699011</pub-id></mixed-citation></ref><ref id="bibr64-1559325818813227"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lavie</surname><given-names>M</given-names></name><name><surname>Voisset</surname><given-names>C</given-names></name><name><surname>Vu-Dac</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system</article-title>. <source>Hepatology</source>. <year>2006</year>;<volume>44</volume>(<issue>6</issue>):<fpage>1626</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">17133472</pub-id></mixed-citation></ref><ref id="bibr65-1559325818813227"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x02019;Keefe</surname><given-names>BR</given-names></name><name><surname>Smee</surname><given-names>DF</given-names></name><name><surname>Turpin</surname><given-names>JA</given-names></name><etal/></person-group>
<article-title>Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2003</year>;<volume>47</volume>(<issue>8</issue>):<comment>2518&#x02013;2125</comment>.</mixed-citation></ref><ref id="bibr66-1559325818813227"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Decker</surname><given-names>JM</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Antibody neutralization and escape by HIV-1</article-title>. <source>Nature</source>. <year>2003</year>;<volume>422</volume>(<issue>6929</issue>):<fpage>307</fpage>&#x02013;<lpage>312</lpage>.<pub-id pub-id-type="pmid">12646921</pub-id></mixed-citation></ref><ref id="bibr67-1559325818813227"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vaillant</surname><given-names>A</given-names></name><name><surname>Juteau</surname><given-names>JM</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2006</year>;<volume>50</volume>(<issue>4</issue>):<fpage>1393</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="pmid">16569857</pub-id></mixed-citation></ref><ref id="bibr68-1559325818813227"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Balzarini</surname><given-names>J</given-names></name></person-group>
<article-title>Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses?</article-title>
<source>Antivir Chem Chemother</source>. <year>2007</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">17354647</pub-id></mixed-citation></ref><ref id="bibr69-1559325818813227"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>De La Fuente</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors</article-title>. <source>J Virol</source>. <year>2001</year>;<volume>75</volume>(<issue>16</issue>):<fpage>7266</fpage>&#x02013;<lpage>7279</lpage>.<pub-id pub-id-type="pmid">11461999</pub-id></mixed-citation></ref><ref id="bibr70-1559325818813227"><label>70</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Montano</surname><given-names>MM</given-names></name><name><surname>Ekena</surname><given-names>K</given-names></name><name><surname>Delage-Mourroux</surname><given-names>R</given-names></name><name><surname>Chang</surname><given-names>W</given-names></name><name><surname>Martini</surname><given-names>P</given-names></name><name><surname>Katzenellenbogen</surname><given-names>BS</given-names></name></person-group>
<article-title>An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>1999</year>;<volume>96</volume>(<issue>12</issue>):<fpage>6947</fpage>&#x02013;<lpage>6952</lpage>.<pub-id pub-id-type="pmid">10359819</pub-id></mixed-citation></ref><ref id="bibr71-1559325818813227"><label>71</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Brown</surname><given-names>LE</given-names></name><etal/></person-group>
<article-title>A novel class of small molecule compounds that inhibit hepatitis C virus infection by targeting the prohibitin&#x02013;CRaf pathway</article-title>. <source>EBioMedicine</source>. <year>2015</year>;<volume>2</volume>(<issue>11</issue>):<fpage>1600</fpage>&#x02013;<lpage>1606</lpage>.<pub-id pub-id-type="pmid">26870784</pub-id></mixed-citation></ref><ref id="bibr72-1559325818813227"><label>72</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calderwood</surname><given-names>DA</given-names></name><name><surname>Shattil</surname><given-names>SJ</given-names></name><name><surname>Ginsberg</surname><given-names>MH</given-names></name></person-group>
<article-title>Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>(<issue>30</issue>):<fpage>22607</fpage>&#x02013;<lpage>22610</lpage>.<pub-id pub-id-type="pmid">10801899</pub-id></mixed-citation></ref><ref id="bibr73-1559325818813227"><label>73</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parolini</surname><given-names>S</given-names></name><name><surname>Bottino</surname><given-names>C</given-names></name><name><surname>Falco</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells</article-title>. <source>J Exp Med</source>. <year>2000</year>;<volume>192</volume>(<issue>3</issue>):<fpage>337</fpage>&#x02013;<lpage>346</lpage>.<pub-id pub-id-type="pmid">10934222</pub-id></mixed-citation></ref><ref id="bibr74-1559325818813227"><label>74</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mori</surname><given-names>N</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Bay 11-7082 inhibits transcription factor NF-&#x003ba;B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells</article-title>. <source>Blood</source>. <year>2002</year>;<volume>100</volume>(<issue>5</issue>):<fpage>1828</fpage>&#x02013;<lpage>1834</lpage>.<pub-id pub-id-type="pmid">12176906</pub-id></mixed-citation></ref><ref id="bibr75-1559325818813227"><label>75</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Tsuchiya</surname><given-names>H</given-names></name><name><surname>Chuhjo</surname><given-names>T</given-names></name><name><surname>Akizawa</surname><given-names>T</given-names></name><name><surname>Seiki</surname><given-names>M</given-names></name></person-group>
<article-title>Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes</article-title>. <source>Genes Dev</source>. <year>1992</year>;<volume>6</volume>(<issue>11</issue>):<fpage>2066</fpage>&#x02013;<lpage>2076</lpage>.<pub-id pub-id-type="pmid">1427072</pub-id></mixed-citation></ref><ref id="bibr76-1559325818813227"><label>76</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Ohtani</surname><given-names>K</given-names></name><name><surname>Iwanaga</surname><given-names>R</given-names></name><name><surname>Matsumura</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name></person-group>
<article-title>Direct transactivation of the human cyclin D2 gene by the oncogene product Tax of human T-cell leukemia virus type I</article-title>. <source>Oncogene</source>. <year>2001</year>;<volume>20</volume>(<issue>9</issue>):<fpage>1094</fpage>&#x02013;<lpage>1102</lpage>.<pub-id pub-id-type="pmid">11314046</pub-id></mixed-citation></ref><ref id="bibr77-1559325818813227"><label>77</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Melville</surname><given-names>MW</given-names></name><name><surname>Tan</surname><given-names>SL</given-names></name><name><surname>Wambach</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Morimoto</surname><given-names>RI</given-names></name><name><surname>Katze</surname><given-names>MG</given-names></name></person-group>
<article-title>The cellular inhibitor of the PKR protein kinase, P58 (IPK), is an influenza virus-activated co-chaperone that modulates heat shock protein 70 activity</article-title>. <source>J Biol Chem</source>. <year>1999</year>;<volume>274</volume>(<issue>6</issue>):<fpage>3797</fpage>&#x02013;<lpage>3803</lpage>.<pub-id pub-id-type="pmid">9920933</pub-id></mixed-citation></ref><ref id="bibr78-1559325818813227"><label>78</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Biron</surname><given-names>CA</given-names></name></person-group>
<article-title>Role of early cytokines, including alpha and beta interferons IFN-(&#x003b1;/&#x003b2;), in innate and adaptive immune responses to viral infections</article-title>. <source>Semin Immunol</source>. <year>1998</year>;<volume>10</volume>:<fpage>383</fpage>&#x02013;<lpage>390</lpage>.<pub-id pub-id-type="pmid">9799713</pub-id></mixed-citation></ref><ref id="bibr79-1559325818813227"><label>79</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Von Hahn</surname><given-names>T</given-names></name><name><surname>Tscherne</surname><given-names>DM</given-names></name><etal/></person-group>
<article-title>Claudin-1 is a hepatitis c virus coreceptor required for a late step in entry</article-title>. <source>Nature</source>
<year>2007</year>;<volume>446</volume>(<issue>7137</issue>):<fpage>801</fpage>&#x02013;<lpage>805</lpage>.<pub-id pub-id-type="pmid">17325668</pub-id></mixed-citation></ref><ref id="bibr80-1559325818813227"><label>80</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ploss</surname><given-names>A</given-names></name><name><surname>Evans</surname><given-names>MJ</given-names></name><name><surname>Gaysinskaya</surname><given-names>VA</given-names></name><etal/></person-group>
<article-title>Human occludin is a hepatitis C virus entry factor required for infection of mouse cells</article-title>. <source>Nature</source>. <year>2009</year>;<volume>457</volume>(<issue>7231</issue>):<fpage>882</fpage>&#x02013;<lpage>886</lpage>.<pub-id pub-id-type="pmid">19182773</pub-id></mixed-citation></ref><ref id="bibr81-1559325818813227"><label>81</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lupberger</surname><given-names>J</given-names></name><name><surname>Zeisel</surname><given-names>MB</given-names></name><name><surname>Xiao</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy</article-title>. <source>Nat Med</source>. <year>2011</year>;<volume>17</volume>(<issue>5</issue>):<fpage>589</fpage>&#x02013;<lpage>595</lpage>.<pub-id pub-id-type="pmid">21516087</pub-id></mixed-citation></ref><ref id="bibr82-1559325818813227"><label>82</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Agnello</surname><given-names>V</given-names></name><name><surname>Abel</surname><given-names>G</given-names></name><name><surname>Elfahal</surname><given-names>M</given-names></name><name><surname>Knight</surname><given-names>GB</given-names></name><name><surname>Zhang</surname><given-names>QX</given-names></name></person-group>
<article-title>Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1999</year>;<volume>96</volume>(<issue>22</issue>):<fpage>12766</fpage>&#x02013;<lpage>12771</lpage>.<pub-id pub-id-type="pmid">10535997</pub-id></mixed-citation></ref><ref id="bibr83-1559325818813227"><label>83</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lozach</surname><given-names>PY</given-names></name><name><surname>Amara</surname><given-names>A</given-names></name><name><surname>Bartosch</surname><given-names>B</given-names></name><etal/></person-group>
<year>2004</year>
<article-title>C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles</article-title>. <source>J Biol Chem</source>. <year>2004</year>;<volume>279</volume>(<issue>31</issue>):<fpage>32035</fpage>&#x02013;<lpage>32045</lpage>.<pub-id pub-id-type="pmid">15166245</pub-id></mixed-citation></ref><ref id="bibr84-1559325818813227"><label>84</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kinghorn</surname><given-names>AD</given-names></name><name><surname>Chin</surname><given-names>YW</given-names></name><name><surname>Swanson</surname><given-names>SM</given-names></name></person-group>
<article-title>Discovery of natural product anticancer agents from biodiverse organisms</article-title>. <source>Curr Opin Drug Discov Dev</source>. <year>2009</year>;<volume>12</volume>(<issue>2</issue>):<fpage>189</fpage>&#x02013;<lpage>196</lpage>.</mixed-citation></ref><ref id="bibr85-1559325818813227"><label>85</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group>
<article-title>Natural products as sources of new drugs over the 30 years from 1981 to 2010</article-title>. <source>J Nat Prod</source>. <year>2012</year>;<volume>75</volume>(<issue>3</issue>):<fpage>311</fpage>&#x02013;<lpage>335</lpage>.<pub-id pub-id-type="pmid">22316239</pub-id></mixed-citation></ref><ref id="bibr86-1559325818813227"><label>86</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Madigan</surname><given-names>MT</given-names></name><name><surname>Martinko</surname><given-names>J</given-names></name><name><surname>Dunlap</surname><given-names>PV</given-names></name><etal/></person-group>
<source>Brock Biology of Microorganisms</source>. <edition>12th ed</edition>
<publisher-loc>Upper Saddle River, NJ</publisher-loc>:<publisher-name>Benjamin Cummings</publisher-name>; <year>2008</year>.</mixed-citation></ref><ref id="bibr87-1559325818813227"><label>87</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tan</surname><given-names>LT</given-names></name></person-group>
<article-title>Bioactive natural products from marine cyanobacteria for drug discovery</article-title>. <source>Phytochemistry</source>. <year>2007</year>;<volume>68</volume>(<issue>7</issue>):<fpage>954</fpage>&#x02013;<lpage>979</lpage>.<pub-id pub-id-type="pmid">17336349</pub-id></mixed-citation></ref><ref id="bibr88-1559325818813227"><label>88</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amato</surname><given-names>A</given-names></name></person-group>
<article-title>Microbes live near undersea CO<sub>2</sub> lake</article-title>. <source>Chem Eng News</source>. <year>2006</year>;<volume>84</volume>(<issue>38</issue>):<fpage>14</fpage>.</mixed-citation></ref><ref id="bibr89-1559325818813227"><label>89</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Short</surname><given-names>PL</given-names></name></person-group>
<article-title>New Zealand plays to its strengths</article-title>. <source>Chem Eng News</source>. <year>2007</year>;<volume>85</volume>(<issue>4</issue>):<fpage>20</fpage>&#x02013;<lpage>21</lpage>.</mixed-citation></ref><ref id="bibr90-1559325818813227"><label>90</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cavicchioli</surname><given-names>R</given-names></name><name><surname>Siddiqui</surname><given-names>KS</given-names></name><name><surname>Andrews</surname><given-names>D</given-names></name><name><surname>Sowers</surname><given-names>KR</given-names></name></person-group>
<article-title>Low-temperature extremophiles and their applications</article-title>. <source>Curr Opin Biotechnol</source>. <year>2002</year>;<volume>13</volume>(<issue>3</issue>):<fpage>253</fpage>&#x02013;<lpage>261</lpage>.<pub-id pub-id-type="pmid">12180102</pub-id></mixed-citation></ref><ref id="bibr91-1559325818813227"><label>91</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banskota</surname><given-names>AH</given-names></name><name><surname>McAlpine</surname><given-names>JB</given-names></name><name><surname>Sorensen</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Genomic analyses lead to novel secondary metabolites. Part 3 ECO-0501, a novel antibacterial of a new class</article-title>. <source>Antibiotics</source>. <year>2006</year>;<volume>59</volume>(<issue>9</issue>):<fpage>533</fpage>&#x02013;<lpage>542</lpage>.</mixed-citation></ref><ref id="bibr92-1559325818813227"><label>92</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>TW</given-names></name><name><surname>Floss</surname><given-names>H</given-names></name></person-group>
<chapter-title>The ansamitocins</chapter-title> In: <person-group person-group-type="editor"><name><surname>Cragg</surname><given-names>GM</given-names></name><name><surname>Kingston</surname><given-names>DGI</given-names></name><name><surname>Newman</surname><given-names>DJ</given-names></name></person-group>, eds. <source>Anticancer Agents from Natural Products</source>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>Brunner-Routledge Psychology Press, Taylor &#x00026; Francis Group</publisher-name>; <year>2005</year>;<fpage>321</fpage>&#x02013;<lpage>338</lpage>. <comment>Chap 17</comment>.</mixed-citation></ref><ref id="bibr93-1559325818813227"><label>93</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Umemura</surname><given-names>K</given-names></name><name><surname>Yanase</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Okutani</surname><given-names>K</given-names></name><name><surname>Yamori</surname><given-names>T</given-names></name><name><surname>Andoh</surname><given-names>T</given-names></name></person-group>
<article-title>Inhibition of DNA topoisomerases I and II, and growth inhibition of human cancer cell lines by a marine microalgal polysaccharide</article-title>. <source>Biochem Pharmacol</source>. <year>2003</year>;<volume>66</volume>(<issue>3</issue>):<fpage>481</fpage>&#x02013;<lpage>487</lpage>.<pub-id pub-id-type="pmid">12907247</pub-id></mixed-citation></ref><ref id="bibr94-1559325818813227"><label>94</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zeng</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>YZ</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>KR</given-names></name><name><surname>Fan</surname><given-names>W</given-names></name></person-group>
<article-title>In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells</article-title>. <source>Clin Cancer Res</source>. <year>2000</year>;<volume>6</volume>(<issue>9</issue>):<fpage>3766</fpage>&#x02013;<lpage>3773</lpage>.<pub-id pub-id-type="pmid">10999771</pub-id></mixed-citation></ref><ref id="bibr95-1559325818813227"><label>95</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cadenas</surname><given-names>ME</given-names></name><name><surname>Sandfrison</surname><given-names>A</given-names></name><name><surname>Cutler</surname><given-names>NS</given-names></name><name><surname>Heitman</surname><given-names>J</given-names></name></person-group>
<article-title>Signal transduction cascades as targets for therapeutic intervention by natural products</article-title>. <source>Trends Biotechnol</source>. <year>1998</year>;<volume>16</volume>(<issue>10</issue>):<fpage>427</fpage>&#x02013;<lpage>433</lpage>.<pub-id pub-id-type="pmid">9807840</pub-id></mixed-citation></ref><ref id="bibr96-1559325818813227"><label>96</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ueda</surname><given-names>H</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Hori</surname><given-names>Y</given-names></name><name><surname>Goto</surname><given-names>T</given-names></name><name><surname>Okuhara</surname><given-names>M</given-names></name></person-group>
<article-title>Action of FR901228, a novel antitumor bicyclic depsipeptide produced by <italic>Chromobacterium violaceum</italic> No. 968 on Ha-Ras transformed NIH3T3 cells</article-title>. <source>Biosci Biotechnol Biochem</source>. <year>1994</year>;<volume>58</volume>(<issue>9</issue>):<fpage>1579</fpage>&#x02013;<lpage>1583</lpage>.<pub-id pub-id-type="pmid">7765477</pub-id></mixed-citation></ref><ref id="bibr97-1559325818813227"><label>97</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tsuruo</surname><given-names>T</given-names></name><name><surname>Oh-hara</surname><given-names>T</given-names></name><name><surname>Iida</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines</article-title>. <source>Cancer Res</source>. <year>1986</year>;<volume>46</volume>(<issue>1</issue>):<fpage>381</fpage>&#x02013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">3753552</pub-id></mixed-citation></ref><ref id="bibr98-1559325818813227"><label>98</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schweitzer</surname><given-names>J</given-names></name><name><surname>Handley</surname><given-names>FG</given-names></name><name><surname>Edwards</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Summary of the workshop on drug development, biological diversity, and economic growth</article-title>. <source>J Natl Cancer Inst</source>. <year>1991</year>;<volume>83</volume>(<issue>18</issue>):<fpage>1294</fpage>&#x02013;<lpage>1298</lpage>.<pub-id pub-id-type="pmid">1679460</pub-id></mixed-citation></ref><ref id="bibr99-1559325818813227"><label>99</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rinehart</surname><given-names>KL</given-names></name></person-group>
<article-title>Antitumor compounds from tunicates</article-title>. <source>Med Res Rev</source>. <year>2000</year>;<volume>20</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">10608919</pub-id></mixed-citation></ref><ref id="bibr100-1559325818813227"><label>100</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chun</surname><given-names>HG</given-names></name><name><surname>Davies</surname><given-names>B</given-names></name><name><surname>Hoth</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Didemnin B&#x02014;the first marine compound entering clinical trials as an antineoplastic agent</article-title>. <source>Invest New Drugs</source>. <year>1986</year>;<volume>4</volume>(<issue>3</issue>):<fpage>279</fpage>&#x02013;<lpage>284</lpage>.<pub-id pub-id-type="pmid">3546184</pub-id></mixed-citation></ref><ref id="bibr101-1559325818813227"><label>101</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Multani</surname><given-names>AS</given-names></name><name><surname>Ozen</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>MA</given-names></name><name><surname>Newman</surname><given-names>RA</given-names></name></person-group>
<article-title>Dolastatin10 induces polyploidy, telomeric associations and apoptosis in a murine melanoma cell line</article-title>. <source>Oncol Rep</source>. <year>1998</year>;<volume>5</volume>(<issue>2</issue>):<fpage>373</fpage>&#x02013;<lpage>376</lpage>.<pub-id pub-id-type="pmid">9468560</pub-id></mixed-citation></ref><ref id="bibr102-1559325818813227"><label>102</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Williams</surname><given-names>PG</given-names></name><name><surname>Asolkar</surname><given-names>RN</given-names></name><name><surname>Kondratyuk</surname><given-names>T</given-names></name><name><surname>Pezzuto</surname><given-names>JM</given-names></name><name><surname>Jensen</surname><given-names>PR</given-names></name><name><surname>Fenical</surname><given-names>W</given-names></name></person-group>
<article-title>Saliniketals A and B, bicyclic polyketides from the marine actinomycete <italic>Salinispora arenicola</italic></article-title>. <source>J Nat Prod</source>. <year>2007</year>;<volume>70</volume>(<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">17253854</pub-id></mixed-citation></ref><ref id="bibr103-1559325818813227"><label>103</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwon</surname><given-names>HC</given-names></name><name><surname>Kauffman</surname><given-names>CA</given-names></name><name><surname>Jensen</surname><given-names>PR</given-names></name><name><surname>Fenical</surname><given-names>W</given-names></name></person-group>
<article-title>Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus &#x0201c;<italic>Marinispora</italic>&#x0201d;</article-title>. <source>J Am Chem Soc</source>. <year>2006</year>;<volume>128</volume>(<issue>5</issue>):<fpage>1622</fpage>&#x02013;<lpage>1632</lpage>.<pub-id pub-id-type="pmid">16448135</pub-id></mixed-citation></ref><ref id="bibr104-1559325818813227"><label>104</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group>
<article-title>Marine natural products and related compounds in clinical and advanced preclinical trials</article-title>. <source>J Nat Prod</source>. <year>2004</year>;<volume>67</volume>(<issue>8</issue>):<fpage>1216</fpage>&#x02013;<lpage>1238</lpage>.<pub-id pub-id-type="pmid">15332835</pub-id></mixed-citation></ref><ref id="bibr105-1559325818813227"><label>105</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aoki</surname><given-names>S</given-names></name><name><surname>Kong</surname><given-names>D</given-names></name><name><surname>Matsui</surname><given-names>K</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name></person-group>
<article-title>Erythroid differentiation in K562 chronic myelogenous cells induced by crambescidin 800, a pentacyclic guanidine alkaloid</article-title>. <source>Anticancer Res</source>. <year>2004</year>;<volume>24</volume>(<issue>4</issue>):<fpage>2325</fpage>&#x02013;<lpage>2330</lpage>.<pub-id pub-id-type="pmid">15330179</pub-id></mixed-citation></ref><ref id="bibr106-1559325818813227"><label>106</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gaitanos</surname><given-names>TN</given-names></name><name><surname>Buey</surname><given-names>RM</given-names></name><name><surname>Diaz</surname><given-names>JF</given-names></name><etal/></person-group>
<article-title>Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines</article-title>. <source>Cancer Res</source>. <year>2004</year>;<volume>64</volume>(<issue>15</issue>):<fpage>5063</fpage>&#x02013;<lpage>5067</lpage>.<pub-id pub-id-type="pmid">15289305</pub-id></mixed-citation></ref><ref id="bibr107-1559325818813227"><label>107</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shim</surname><given-names>JS</given-names></name><name><surname>Lee</surname><given-names>HS</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Kwon</surname><given-names>HJ</given-names></name></person-group>
<article-title>Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro</article-title>. <source>Cancer Lett</source>. <year>2004</year>;<volume>203</volume>(<issue>2</issue>):<fpage>163</fpage>&#x02013;<lpage>169</lpage>.<pub-id pub-id-type="pmid">14732224</pub-id></mixed-citation></ref><ref id="bibr108-1559325818813227"><label>108</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>SS</given-names></name><name><surname>Biggs</surname><given-names>J</given-names></name><name><surname>Copp</surname><given-names>BR</given-names></name><name><surname>Holden</surname><given-names>JA</given-names></name><name><surname>Barrows</surname><given-names>LR</given-names></name></person-group>
<article-title>Mechanism of ascididemin-induced cytotoxicity</article-title>. <source>Chem Res Toxicol</source>. <year>2003</year>;<volume>16</volume>(<issue>2</issue>):<fpage>113</fpage>&#x02013;<lpage>122</lpage>.<pub-id pub-id-type="pmid">12588181</pub-id></mixed-citation></ref><ref id="bibr109-1559325818813227"><label>109</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dirsch</surname><given-names>VM</given-names></name><name><surname>Muller</surname><given-names>IM</given-names></name><name><surname>Eichhorst</surname><given-names>ST</given-names></name><etal/></person-group>
<article-title>Cephalostatin 1 selectively triggers the release of Smac/DIABLO and subsequent apoptosis that is characterized by an increased density of the mitochondrial matrix</article-title>. <source>Cancer Res</source>. <year>2003</year>;<volume>63</volume>(<issue>24</issue>):<fpage>8869</fpage>&#x02013;<lpage>8876</lpage>.<pub-id pub-id-type="pmid">14695204</pub-id></mixed-citation></ref><ref id="bibr110-1559325818813227"><label>110</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schwartsmann</surname><given-names>G</given-names></name></person-group>
<article-title>Marine organisms and other novel natural sources of new cancer drugs</article-title>. <source>Ann Oncol</source>. <year>2000</year>;<volume>11</volume>(<issue>suppl 3</issue>):<fpage>235</fpage>&#x02013;<lpage>243</lpage>.</mixed-citation></ref><ref id="bibr111-1559325818813227"><label>111</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Poncet</surname><given-names>J</given-names></name></person-group>
<article-title>The dolastatins, a family of promising antineoplastic agents</article-title>. <source>Curr Pharm Des</source>. <year>1999</year>;<volume>5</volume>(<issue>3</issue>):<fpage>139</fpage>&#x02013;<lpage>162</lpage>.<pub-id pub-id-type="pmid">10066887</pub-id></mixed-citation></ref><ref id="bibr112-1559325818813227"><label>112</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pettit</surname><given-names>GR</given-names></name></person-group>
<article-title>The bryostatins</article-title>. <source>Fortschritte Chem Organ Nat</source>. <year>1991</year>;<volume>57</volume>:<fpage>153</fpage>&#x02013;<lpage>195</lpage>.</mixed-citation></ref><ref id="bibr113-1559325818813227"><label>113</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>I</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name></person-group>
<article-title>Antitumor marine natural products</article-title>. <source>Gan To Kagaku Ryoho</source>. <year>1990</year>;<volume>17</volume>(<issue>3 pt 1</issue>):<fpage>322</fpage>&#x02013;<lpage>329</lpage>.<pub-id pub-id-type="pmid">2310201</pub-id></mixed-citation></ref><ref id="bibr114-1559325818813227"><label>114</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dossey</surname><given-names>AT</given-names></name></person-group>
<article-title>Insects and their chemical weaponry: new potential for drug discovery</article-title>. <source>Nat Prod Rep</source>. <year>2010</year>;<volume>27</volume>(<issue>12</issue>):<fpage>1737</fpage>&#x02013;<lpage>1757</lpage>.<pub-id pub-id-type="pmid">20957283</pub-id></mixed-citation></ref><ref id="bibr115-1559325818813227"><label>115</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Slocinska</surname><given-names>M</given-names></name><name><surname>Marciniak</surname><given-names>P</given-names></name><name><surname>Rosinski</surname><given-names>G</given-names></name></person-group>
<article-title>Insect&#x02019;s antiviral and anticancer peptides: new leads for the future?</article-title>
<source>Protein Peptide Lett</source>. <year>2008</year>;<volume>15</volume>(<issue>6</issue>):<fpage>578</fpage>&#x02013;<lpage>585</lpage>.</mixed-citation></ref><ref id="bibr116-1559325818813227"><label>116</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kokoza</surname><given-names>V</given-names></name><name><surname>Ahmed</surname><given-names>A</given-names></name><name><surname>Woon Shin</surname><given-names>S</given-names></name><name><surname>Okafor</surname><given-names>N</given-names></name><name><surname>Zou</surname><given-names>Z</given-names></name><name><surname>Raikhel</surname><given-names>AS</given-names></name></person-group>
<article-title>Blocking of <italic>Plasmodium</italic> transmission by cooperative action of cecropin A and defensin A in transgenic <italic>Aedes aegypti</italic> mosquitoes</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2010</year>;<volume>107</volume>(<issue>18</issue>):<fpage>8111</fpage>&#x02013;<lpage>8116</lpage>.<pub-id pub-id-type="pmid">20385844</pub-id></mixed-citation></ref><ref id="bibr117-1559325818813227"><label>117</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Jeong</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>KK</given-names></name><etal/></person-group>
<article-title>Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-&#x003ba;B and AP-1-dependent MMP-9 expression</article-title>. <source>Mol Cells</source>. <year>2010</year>;<volume>29</volume>(<issue>2</issue>):<fpage>209</fpage>&#x02013;<lpage>215</lpage>.<pub-id pub-id-type="pmid">20082219</pub-id></mixed-citation></ref><ref id="bibr118-1559325818813227"><label>118</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Molecular evidences for the biosynthesis of pederin by endosymbiont</article-title>. <source>Agr Sci China</source>. <year>2009</year>;<volume>8</volume>:<fpage>1339</fpage>&#x02013;<lpage>1350</lpage>.</mixed-citation></ref><ref id="bibr119-1559325818813227"><label>119</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Izuta</surname><given-names>H</given-names></name><name><surname>Chikaraishi</surname><given-names>Y</given-names></name><name><surname>Shimazawa</surname><given-names>M</given-names></name><name><surname>Mishima</surname><given-names>S</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name></person-group>
<article-title>10-Hydroxy-2-decenoic acid, a major fatty acid from Royal Jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells</article-title>. <source>Evid Complement Altern Med</source>. <year>2009</year>;<volume>6</volume>(<issue>4</issue>):<fpage>489</fpage>&#x02013;<lpage>494</lpage>.</mixed-citation></ref><ref id="bibr120-1559325818813227"><label>120</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>KR</given-names></name><name><surname>Zhang</surname><given-names>BZ</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Yan</surname><given-names>JX</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name></person-group>
<article-title>Antitumor effects, cell selectivity and structure activity relationship of a novel antimicrobial peptide polybia-MPI</article-title>. <source>Peptides</source>. <year>2008</year>;<volume>29</volume>(<issue>6</issue>):<fpage>963</fpage>&#x02013;<lpage>968</lpage>.<pub-id pub-id-type="pmid">18328599</pub-id></mixed-citation></ref><ref id="bibr121-1559325818813227"><label>121</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arbiser</surname><given-names>JL</given-names></name><name><surname>Kau</surname><given-names>T</given-names></name><name><surname>Konar</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Solenopsin, the alkaloidal component of the fire ant (<italic>Solenopsis invicta</italic>), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis</article-title>. <source>Blood</source>. <year>2007</year>;<volume>109</volume>(<issue>2</issue>):<fpage>560</fpage>&#x02013;<lpage>565</lpage>.<pub-id pub-id-type="pmid">16990598</pub-id></mixed-citation></ref><ref id="bibr122-1559325818813227"><label>122</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rauh</surname><given-names>R</given-names></name><name><surname>Kahl</surname><given-names>S</given-names></name><name><surname>Boechzelt</surname><given-names>H</given-names></name><name><surname>Bauer</surname><given-names>R</given-names></name><name><surname>Kaina</surname><given-names>B</given-names></name><name><surname>Efferth</surname><given-names>T</given-names></name></person-group>
<article-title>Molecular biology of cantharidin in cancer cells</article-title>. <source>Chin Med</source>. <year>2007</year>;<volume>2</volume>:<fpage>8</fpage>.<pub-id pub-id-type="pmid">17610718</pub-id></mixed-citation></ref><ref id="bibr123-1559325818813227"><label>123</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shiga</surname><given-names>A</given-names></name><name><surname>Kakamu</surname><given-names>S</given-names></name><name><surname>Sugiyama</surname><given-names>Y</given-names></name><name><surname>Shibata</surname><given-names>M</given-names></name><name><surname>Makino</surname><given-names>E</given-names></name><name><surname>Enomoto</surname><given-names>M</given-names></name></person-group>
<article-title>Acute toxicity of pierisin-1, a cytotoxic protein from <italic>Pieris rapae</italic>, in mouse and rat</article-title>. <source>J Toxicol Sci</source>. <year>2006</year>;<volume>31</volume>(<issue>2</issue>):<fpage>123</fpage>&#x02013;<lpage>137</lpage>.<pub-id pub-id-type="pmid">16772702</pub-id></mixed-citation></ref><ref id="bibr124-1559325818813227"><label>124</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turati</surname><given-names>F</given-names></name><name><surname>Rossi</surname><given-names>M</given-names></name><name><surname>Pelucchi</surname><given-names>C</given-names></name><name><surname>Levi</surname><given-names>F</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name></person-group>
<article-title>Fruit and vegetables and cancer risk: a review of southern European studies</article-title>. <source>Br J Nutr</source>. <year>2015</year>;<volume>113</volume>(<issue>suppl 3</issue>):<fpage>102</fpage>&#x02013;<lpage>110</lpage>.</mixed-citation></ref><ref id="bibr125-1559325818813227"><label>125</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><etal/></person-group>
<article-title>Polysaccharides from <italic>Tricholoma matsutake</italic> and <italic>Lentinus edodes</italic> enhance 5-fluorouracil-mediated H22 cell growth inhibition</article-title>. <source>J Trad Chin Med</source>. <year>2014</year>;<volume>34</volume>(<issue>3</issue>):<fpage>309</fpage>&#x02013;<lpage>316</lpage>.</mixed-citation></ref><ref id="bibr126-1559325818813227"><label>126</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sudan</surname><given-names>S</given-names></name><name><surname>Rupasinghe</surname><given-names>HP</given-names></name></person-group>
<article-title>Flavonoid-enriched apple fraction AF4 induces cell cycle arrest, DNA topoisomerase II inhibition, and apoptosis in human liver cancer HepG2 cells</article-title>. <source>Nutr Cancer</source>. <year>2014</year>;<volume>66</volume>(<issue>7</issue>):<fpage>1237</fpage>&#x02013;<lpage>1246</lpage>.<pub-id pub-id-type="pmid">25256427</pub-id></mixed-citation></ref><ref id="bibr127-1559325818813227"><label>127</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>HF</given-names></name><name><surname>Wu</surname><given-names>CH</given-names></name><name><surname>Yang</surname><given-names>LL</given-names></name></person-group>
<article-title>Antitumour and free radical scavenging effects of &#x003b3;-mangostin isolated from <italic>Garcinia mangostana</italic> pericarps against hepatocellular carcinoma cell</article-title>. <source>J Pharm Pharmacol</source>. <year>2013</year>;<volume>65</volume>(<issue>9</issue>):<fpage>1419</fpage>&#x02013;<lpage>1428</lpage>.<pub-id pub-id-type="pmid">23927480</pub-id></mixed-citation></ref><ref id="bibr128-1559325818813227"><label>128</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chavan</surname><given-names>SS</given-names></name><name><surname>Manoj</surname><given-names>GD</given-names></name><name><surname>Prashant</surname><given-names>BS</given-names></name><etal/></person-group>
<article-title>Traditional medicinal plants for anticancer activity</article-title>. <source>Int J Curr Pharm Res</source>. <year>2013</year>;<volume>5</volume>(<issue>4</issue>):<fpage>50</fpage>&#x02013;<lpage>54</lpage>.</mixed-citation></ref><ref id="bibr129-1559325818813227"><label>129</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>SS</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name><etal/></person-group>
<article-title>Anti-tumor activity of <italic>Annona squamosa</italic> seeds extract containing annonaceous acetogenin compounds</article-title>. <source>J Ethnopharmacol</source>. <year>2012</year>;<volume>142</volume>(<issue>2</issue>):<fpage>462</fpage>&#x02013;<lpage>466</lpage>.<pub-id pub-id-type="pmid">22609808</pub-id></mixed-citation></ref><ref id="bibr130-1559325818813227"><label>130</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Smoliga</surname><given-names>JM</given-names></name><name><surname>Baur</surname><given-names>JA</given-names></name><name><surname>Hausenblas</surname><given-names>HA</given-names></name></person-group>
<article-title>Resveratrol and health&#x02014;a comprehensive review of human clinical trials</article-title>. <source>Mol Nutr Food Res</source>. <year>2011</year>;<volume>55</volume>(<issue>8</issue>):<fpage>1129</fpage>&#x02013;<lpage>1141</lpage>.<pub-id pub-id-type="pmid">21688389</pub-id></mixed-citation></ref><ref id="bibr131-1559325818813227"><label>131</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Govind</surname><given-names>P</given-names></name></person-group>
<article-title>Some important anticancer herbs: a review</article-title>. <source>Int Res J Pharm</source>. <year>2011</year>;<volume>2</volume>(<issue>7</issue>):<fpage>45</fpage>&#x02013;<lpage>52</lpage>.</mixed-citation></ref><ref id="bibr132-1559325818813227"><label>132</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yu</surname><given-names>MH</given-names></name><name><surname>Im</surname><given-names>HG</given-names></name><name><surname>Kim</surname><given-names>HI</given-names></name><name><surname>Lee</surname><given-names>IS</given-names></name></person-group>
<article-title>Induction of apoptosis by immature plum in human hepatocellular carcinoma</article-title>. <source>J Med Food</source>. <year>2009</year>;<volume>12</volume>(<issue>3</issue>):<fpage>518</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="pmid">19627199</pub-id></mixed-citation></ref><ref id="bibr133-1559325818813227"><label>133</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jo</surname><given-names>JY</given-names></name><name><surname>De Mejia</surname><given-names>EG</given-names></name><name><surname>Lila</surname><given-names>MA</given-names></name></person-group>
<article-title>Cytotoxicity of bioactive polymeric fractions from grape cell culture on human hepatocellular carcinoma, murine leukemia and non-cancerous PK15 kidney cells</article-title>. <source>Food Chem Toxicol</source>. <year>2006</year>;<volume>44</volume>(<issue>10</issue>):<fpage>1758</fpage>&#x02013;<lpage>1767</lpage>.<pub-id pub-id-type="pmid">16828532</pub-id></mixed-citation></ref><ref id="bibr134-1559325818813227"><label>134</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>D</given-names></name><name><surname>Egea</surname><given-names>J</given-names></name><name><surname>Tomas-Barberan</surname><given-names>FA</given-names></name><name><surname>Gil</surname><given-names>MI</given-names></name></person-group>
<article-title>Carotenoids from new apricot (<italic>Prunus armeniaca</italic> L.) varieties and their relationship with flesh and skin color</article-title>. <source>J Agri Food Chem</source>. <year>2005</year>;<volume>53</volume>(<issue>16</issue>):<fpage>6368</fpage>&#x02013;<lpage>6374</lpage>.</mixed-citation></ref><ref id="bibr135-1559325818813227"><label>135</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Ya</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>HB</given-names></name></person-group>
<article-title>Dietary natural products for prevention and treatment of liver cancer</article-title>. <source>Nutrients</source>. <year>2016</year>;<volume>8</volume>(<issue>3</issue>):<fpage>156</fpage>.<pub-id pub-id-type="pmid">26978396</pub-id></mixed-citation></ref><ref id="bibr136-1559325818813227"><label>136</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>CZ</given-names></name><name><surname>Fang</surname><given-names>EF</given-names></name><name><surname>Zhang</surname><given-names>HT</given-names></name><name><surname>Liu</surname><given-names>LL</given-names></name><name><surname>Yun</surname><given-names>JP</given-names></name></person-group>
<article-title><italic>Momordica charantia</italic> lectin exhibits antitumor activity towards hepatocellular carcinoma</article-title>. <source>Invest New Drugs</source>. <year>2015</year>;<volume>33</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">25200916</pub-id></mixed-citation></ref><ref id="bibr137-1559325818813227"><label>137</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xiang</surname><given-names>J</given-names></name><name><surname>Xiang</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Anticancer effects of deproteinized asparagus polysaccharide on hepatocellular carcinoma in vitro and in vivo</article-title>. <source>Tumour Biol</source>. <year>2014</year>;<volume>35</volume>(<issue>4</issue>):<fpage>3517</fpage>&#x02013;<lpage>3524</lpage>.<pub-id pub-id-type="pmid">24310501</pub-id></mixed-citation></ref><ref id="bibr138-1559325818813227"><label>138</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gupta</surname><given-names>P</given-names></name><name><surname>Bansal</surname><given-names>MP</given-names></name><name><surname>Koul</surname><given-names>A</given-names></name></person-group>
<article-title>Evaluating the effect of lycopene from <italic>Lycopersicum esculentum</italic> on apoptosis during NDEA induced hepatocarcinogenesis</article-title>. <source>Biochem Biophys Res Commun</source>. <year>2013</year>;<volume>434</volume>(<issue>4</issue>):<fpage>479</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">23583393</pub-id></mixed-citation></ref><ref id="bibr139-1559325818813227"><label>139</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hafidh</surname><given-names>RR</given-names></name><name><surname>Abdulamir</surname><given-names>AS</given-names></name><name><surname>Bakar</surname><given-names>FA</given-names></name><name><surname>Jalilian</surname><given-names>FA</given-names></name><name><surname>Abas</surname><given-names>F</given-names></name><name><surname>Sekawi</surname><given-names>Z</given-names></name></person-group>
<article-title>Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of mung bean sprouts</article-title>. <source>BMC Complement Altern Med</source>. <year>2012</year>;<volume>12</volume>:<fpage>208</fpage>.<pub-id pub-id-type="pmid">23122182</pub-id></mixed-citation></ref><ref id="bibr140-1559325818813227"><label>140</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fang</surname><given-names>EF</given-names></name><name><surname>Pan</surname><given-names>WL</given-names></name><name><surname>Wong</surname><given-names>JH</given-names></name><name><surname>Chan</surname><given-names>YS</given-names></name><name><surname>Ye</surname><given-names>XJ</given-names></name><name><surname>Ng</surname><given-names>TB</given-names></name></person-group>
<article-title>A new <italic>Phaseolus vulgaris</italic> lectin induces selective toxicity on human liver carcinoma Hep G2 cells</article-title>. <source>Arch Toxicol</source>. <year>2011</year>;<volume>85</volume>(<issue>12</issue>):<fpage>1551</fpage>&#x02013;<lpage>1563</lpage>.<pub-id pub-id-type="pmid">21445585</pub-id></mixed-citation></ref><ref id="bibr141-1559325818813227"><label>141</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedman</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>KR</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>IS</given-names></name><name><surname>Kozukue</surname><given-names>N</given-names></name></person-group>
<article-title>Anticarcinogenic effects of glycoalkaloids from potatoes against human cervical, liver, lymphoma, and stomach cancer cells</article-title>. <source>J Agric Food Chem</source>. <year>2005</year>;<volume>5</volume>
<issue>3(15</issue>):<fpage>6162</fpage>&#x02013;<lpage>6169</lpage>.</mixed-citation></ref><ref id="bibr142-1559325818813227"><label>142</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sultana</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Jahangir</surname><given-names>T</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group>
<article-title>Inhibitory effect of celery seeds extract on chemically induced hepatocarcinogenesis: modulation of cell proliferation, metabolism and altered hepatic foci development</article-title>. <source>Cancer Lett</source>. <year>2005</year>;<volume>221</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">15797622</pub-id></mixed-citation></ref><ref id="bibr143-1559325818813227"><label>143</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kleijnen</surname><given-names>J</given-names></name><name><surname>Knipschild</surname><given-names>P</given-names></name></person-group>
<article-title><italic>Gingko biloba</italic> for cerebral insufficiency</article-title>. <source>Br J Clin Pharmacol</source>. <year>1992</year>;<volume>34</volume>(<issue>4</issue>):<fpage>352</fpage>&#x02013;<lpage>358</lpage>.<pub-id pub-id-type="pmid">1457269</pub-id></mixed-citation></ref><ref id="bibr144-1559325818813227"><label>144</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Martin</surname><given-names>RC</given-names></name></person-group>
<article-title>Hepatic protection and anticancer activity of curcuma: a potential chemopreventive strategy against hepatocellular carcinoma</article-title>. <source>Int J Oncol</source>. <year>2014</year>;<volume>44</volume>(<issue>2</issue>):<fpage>505</fpage>&#x02013;<lpage>513</lpage>.<pub-id pub-id-type="pmid">24270742</pub-id></mixed-citation></ref><ref id="bibr145-1559325818813227"><label>145</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chang</surname><given-names>HS</given-names></name><name><surname>Ko</surname><given-names>M</given-names></name><name><surname>Ishizuka</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Sodium 2-propenyl thiosulfate derived from garlic induces phase II detoxification enzymes in rat hepatoma H4IIE cells</article-title>. <source>Nutr Res</source>. <year>2010</year>;<volume>30</volume>(<issue>6</issue>):<fpage>435</fpage>&#x02013;<lpage>440</lpage>.<pub-id pub-id-type="pmid">20650352</pub-id></mixed-citation></ref><ref id="bibr146-1559325818813227"><label>146</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chu</surname><given-names>YL</given-names></name><name><surname>Ho</surname><given-names>CT</given-names></name><name><surname>Chung</surname><given-names>JG</given-names></name><name><surname>Raghu</surname><given-names>R</given-names></name><name><surname>Lo</surname><given-names>YC</given-names></name><name><surname>Sheen</surname><given-names>LY</given-names></name></person-group>
<article-title>Allicin induces anti-human liver cancer cells through the p53 gene modulating apoptosis and autophagy</article-title>. <source>J Agric Food Chem</source>. <year>2013</year>;<volume>61</volume>(<issue>41</issue>):<fpage>9839</fpage>&#x02013;<lpage>9848</lpage>.<pub-id pub-id-type="pmid">24059278</pub-id></mixed-citation></ref><ref id="bibr147-1559325818813227"><label>147</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>SP</given-names></name><name><surname>Chen</surname><given-names>JC</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>Capsaicin-induced apoptosis in human hepatoma HepG2 cells</article-title>. <source>Anticancer Res</source>. <year>2009</year>;<volume>29</volume>(<issue>1</issue>):<fpage>165</fpage>&#x02013;<lpage>174</lpage>.<pub-id pub-id-type="pmid">19331147</pub-id></mixed-citation></ref><ref id="bibr148-1559325818813227"><label>148</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vijaya</surname><given-names>PV</given-names></name><name><surname>Arul</surname><given-names>DCS</given-names></name><name><surname>Ramkuma</surname><given-names>KM</given-names></name></person-group>
<article-title>Induction of apoptosis by ginger in HEp-2 cell line is mediated by reactive oxygen species</article-title>. <source>Basic Clin Pharmacol Toxicol</source>. <year>2007</year>;<volume>100</volume>(<issue>5</issue>):<fpage>302</fpage>&#x02013;<lpage>307</lpage>.<pub-id pub-id-type="pmid">17448115</pub-id></mixed-citation></ref><ref id="bibr149-1559325818813227"><label>149</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abdullaev</surname><given-names>FI</given-names></name></person-group>
<article-title>Cancer chemopreventive and tumoricidal properties of saffron (<italic>Crocus sativus</italic> L.)</article-title>. <source>Exp Biol Med</source>. <year>2002</year>;<volume>227</volume>(<issue>1</issue>):<fpage>20</fpage>&#x02013;<lpage>25</lpage>.</mixed-citation></ref><ref id="bibr150-1559325818813227"><label>150</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>YS</given-names></name></person-group>
<article-title>Role of NADPH oxidase-mediated generation of reactive oxygen species in the mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells</article-title>. <source>Arch Pharmacol Res</source>. <year>2005</year>;<volume>28</volume>(<issue>10</issue>):<fpage>1183</fpage>&#x02013;<lpage>1189</lpage>.</mixed-citation></ref><ref id="bibr151-1559325818813227"><label>151</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>YB</given-names></name><name><surname>Tripathi</surname><given-names>B</given-names></name><name><surname>Arjmandi</surname><given-names>BH</given-names></name></person-group>
<article-title>Nutraceuticals and cancer management</article-title>. <source>Front Biosci</source>. <year>2005</year>;<volume>10</volume>:<fpage>1607</fpage>&#x02013;<lpage>1618</lpage>.<pub-id pub-id-type="pmid">15769650</pub-id></mixed-citation></ref><ref id="bibr152-1559325818813227"><label>152</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Oz</surname><given-names>HS</given-names></name><name><surname>Barve</surname><given-names>S</given-names></name><name><surname>de Villiers</surname><given-names>WJ</given-names></name><name><surname>McClain</surname><given-names>CJ</given-names></name><name><surname>Varilek</surname><given-names>GW</given-names></name></person-group>
<article-title>The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6</article-title>. <source>Mol Pharmacol</source>. <year>2001</year>;<volume>60</volume>(<issue>3</issue>):<fpage>528</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">11502884</pub-id></mixed-citation></ref><ref id="bibr153-1559325818813227"><label>153</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Al-Fatlawi</surname><given-names>AA</given-names></name><name><surname>Irshad</surname><given-names>M</given-names></name><name><surname>Zafaryab</surname><given-names>M</given-names></name><name><surname>Zafaryab</surname><given-names>M</given-names></name><name><surname>Rizvi</surname><given-names>MM</given-names></name><name><surname>Ahmad</surname><given-names>A</given-names></name></person-group>
<article-title>Rice bran phytic acid induced apoptosis through regulation of Bcl-2/Bax and p53 genes in HepG2 human hepatocellular carcinoma cells</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2014</year>;<volume>15</volume>(<issue>8</issue>):<fpage>3731</fpage>&#x02013;<lpage>3736</lpage>.<pub-id pub-id-type="pmid">24870784</pub-id></mixed-citation></ref><ref id="bibr154-1559325818813227"><label>154</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group>
<article-title>Anti-hepatoma activity and mechanism of corn silk polysaccharides in H22 tumor-bearing mice</article-title>. <source>Int J Biol Macromol</source>. <year>2014</year>;<volume>64</volume>:<fpage>276</fpage>&#x02013;<lpage>280</lpage>.<pub-id pub-id-type="pmid">24315949</pub-id></mixed-citation></ref><ref id="bibr155-1559325818813227"><label>155</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>WW</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Lai</surname><given-names>ET</given-names></name><etal/></person-group>
<article-title>Water extract from <italic>Pleurotus pulmonarius</italic> with antioxidant activity exerts in vivo chemoprophylaxis and chemosensitization for liver cancer</article-title>. <source>Nutr Cancer</source>. <year>2014</year>;<volume>66</volume>(<issue>6</issue>):<fpage>989</fpage>&#x02013;<lpage>998</lpage>.<pub-id pub-id-type="pmid">25072857</pub-id></mixed-citation></ref><ref id="bibr156-1559325818813227"><label>156</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yukawa</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>S</given-names></name><name><surname>Kawanishi</surname><given-names>T</given-names></name><name><surname>Tamesada</surname><given-names>M</given-names></name><name><surname>Tomi</surname><given-names>H</given-names></name></person-group>
<article-title>Direct cytotoxicity of <italic>Lentinula edodes</italic> mycelia extract on human hepatocellular carcinoma cell line</article-title>. <source>Biol Pharm Bull</source>. <year>2012</year>;<volume>35</volume>(<issue>7</issue>):<fpage>1014</fpage>&#x02013;<lpage>1021</lpage>.<pub-id pub-id-type="pmid">22791146</pub-id></mixed-citation></ref><ref id="bibr157-1559325818813227"><label>157</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>A novel lectin from <italic>Agrocybe aegerita</italic> shows high binding selectivity for terminal N-acetylglucosamine</article-title>. <source>Biochem J</source>. <year>2012</year>;<volume>443</volume>(<issue>2</issue>):<fpage>369</fpage>&#x02013;<lpage>378</lpage>.<pub-id pub-id-type="pmid">22268569</pub-id></mixed-citation></ref><ref id="bibr158-1559325818813227"><label>158</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Angeli</surname><given-names>JP</given-names></name><name><surname>Ribeiro</surname><given-names>LR</given-names></name><name><surname>Bellini</surname><given-names>MF</given-names></name><name><surname>Mantovani</surname><given-names>MS</given-names></name></person-group>
<article-title>. &#x003b2;-glucan extracted from the medicinal mushroom <italic>Agaricus blazei</italic> prevents the genotoxic effects of benzo(&#x003b1;)pyrene in the human hepatoma cell line HepG2</article-title>. <source>Arch Toxicol</source>. <year>2009</year>;<volume>83</volume>(<issue>1</issue>):<fpage>81</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="pmid">18528685</pub-id></mixed-citation></ref><ref id="bibr159-1559325818813227"><label>159</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>JT</given-names></name><name><surname>Liu</surname><given-names>WH</given-names></name></person-group>
<article-title>o-Orsellinaldehyde from the submerged culture of the edible mushroom <italic>Grifola frondosa</italic> exhibits selective cytotoxic effect against Hep 3B cells through apoptosis</article-title>. <source>J Agric Food Chem</source>. <year>2006</year>;<volume>54</volume>(<issue>20</issue>):<fpage>7564</fpage>&#x02013;<lpage>7569</lpage>.<pub-id pub-id-type="pmid">17002422</pub-id></mixed-citation></ref><ref id="bibr160-1559325818813227"><label>160</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Smith</surname><given-names>JE</given-names></name><name><surname>Rowan</surname><given-names>NK</given-names></name><name><surname>Sullivan</surname><given-names>R.</given-names></name></person-group>
<source>Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatments</source>. <publisher-loc>London</publisher-loc>, <publisher-name>United Kingdom: Cancer Research UK</publisher-name>; <year>2000</year>:<fpage>220</fpage>.</mixed-citation></ref><ref id="bibr161-1559325818813227"><label>161</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hwang</surname><given-names>BY</given-names></name><name><surname>Su</surname><given-names>BN</given-names></name><name><surname>Chai</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from <italic>Aglaia silvestris</italic></article-title>. <source>J Org Chem</source>. <year>2004</year>;<volume>69</volume>(<issue>10</issue>):<fpage>3350</fpage>&#x02013;<lpage>3358</lpage>.<pub-id pub-id-type="pmid">15132542</pub-id></mixed-citation></ref><ref id="bibr162-1559325818813227"><label>162</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pecere</surname><given-names>T</given-names></name><name><surname>Gazzola</surname><given-names>MV</given-names></name><name><surname>Micignat</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors</article-title>. <source>Cancer Res</source>. <year>2000</year>;<volume>60</volume>(<issue>11</issue>):<fpage>2800</fpage>&#x02013;<lpage>2804</lpage>.<pub-id pub-id-type="pmid">10850417</pub-id></mixed-citation></ref><ref id="bibr163-1559325818813227"><label>163</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whelan</surname><given-names>LC</given-names></name><name><surname>Ryan</surname><given-names>MF</given-names></name></person-group>
<article-title>Effects of the polyacetylene capillin on human tumour cell lines</article-title>. <source>Anticancer Res</source>. <year>2004</year>;<volume>24</volume>(<issue>4</issue>):<fpage>2281</fpage>&#x02013;<lpage>2286</lpage>.<pub-id pub-id-type="pmid">15330173</pub-id></mixed-citation></ref><ref id="bibr164-1559325818813227"><label>164</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Bhat</surname><given-names>KPL</given-names></name><name><surname>Fong</surname><given-names>HH</given-names></name><name><surname>Farnsworth</surname><given-names>NR</given-names></name><name><surname>Pezzuto</surname><given-names>JM</given-names></name><name><surname>Kinghorn</surname><given-names>AD</given-names></name></person-group>
<article-title>Aromatase inhibitors from <italic>Broussonetia papyrifera</italic></article-title>. <source>J Nat Prod</source>. <year>2001</year>;<volume>64</volume>(<issue>10</issue>):<fpage>1286</fpage>&#x02013;<lpage>1293</lpage>.<pub-id pub-id-type="pmid">11678652</pub-id></mixed-citation></ref><ref id="bibr165-1559325818813227"><label>165</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cuendet</surname><given-names>M</given-names></name><name><surname>Pezzuto</surname><given-names>JM</given-names></name></person-group>
<article-title>Antitumor activity of bruceantin. An old drug with new promise</article-title>. <source>J Nat Prod</source>. <year>2004</year>;<volume>67</volume>(<issue>2</issue>):<fpage>269</fpage>&#x02013;<lpage>272</lpage>.<pub-id pub-id-type="pmid">14987068</pub-id></mixed-citation></ref><ref id="bibr166-1559325818813227"><label>166</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cragg</surname><given-names>GM</given-names></name><name><surname>Newman</surname><given-names>DJ</given-names></name></person-group>
<article-title>Plants as a source of anticancer agents</article-title>. <source>J Ethnopharmacol</source>. <year>2005</year>;<volume>100</volume>(<issue>1-2</issue>):<fpage>72</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">16009521</pub-id></mixed-citation></ref><ref id="bibr167-1559325818813227"><label>167</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Mohammad</surname><given-names>M</given-names></name><name><surname>Sarkar</surname><given-names>FH</given-names></name><name><surname>Mohammad</surname><given-names>RM</given-names></name></person-group>
<article-title>Efficacy of selected natural products as therapeutic agents against cancer</article-title>. <source>J Nat Prod</source>. <year>2008</year>;<volume>71</volume>(<issue>3</issue>):<fpage>492</fpage>&#x02013;<lpage>496</lpage>.<pub-id pub-id-type="pmid">18302335</pub-id></mixed-citation></ref><ref id="bibr168-1559325818813227"><label>168</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hartwell</surname><given-names>JL</given-names></name></person-group>
<article-title>Plants used against cancer</article-title>. <source>Lloydia</source>. <year>1969</year>;<volume>32</volume>:<fpage>158</fpage>&#x02013;<lpage>176</lpage>.</mixed-citation></ref><ref id="bibr169-1559325818813227"><label>169</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silva</surname><given-names>GL</given-names></name><name><surname>Cui</surname><given-names>B</given-names></name><name><surname>Chavez</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Modulation of the multidrug-resistance phenotype by new tropane alkaloid aromatic esters from <italic>Erythroxylum pervillei</italic></article-title>. <source>J Nat Prod</source>. <year>2001</year>;<volume>64</volume>(<issue>12</issue>):<fpage>1514</fpage>&#x02013;<lpage>1520</lpage>.<pub-id pub-id-type="pmid">11754602</pub-id></mixed-citation></ref><ref id="bibr170-1559325818813227"><label>170</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Tyler</surname><given-names>V</given-names></name></person-group>
<source>Herbs of Choice. The Therapeutic Use of Phytomedicinals</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Haworth Press</publisher-name>; <year>1994</year>:<fpage>32</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="bibr171-1559325818813227"><label>171</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ambasta</surname><given-names>SP</given-names></name></person-group>
<source>The Useful Plant of India</source>. <edition>4th ed</edition>
<publisher-loc>Delhi, India</publisher-loc>: <publisher-name>National Institution of Science Communication</publisher-name>; <year>2000</year>:<fpage>239</fpage>.</mixed-citation></ref><ref id="bibr172-1559325818813227"><label>172</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Ambasta</surname><given-names>SP</given-names></name></person-group>
<source>The Useful Plant of India</source>. <edition>4th ed</edition>
<publisher-loc>Delhi, India</publisher-loc>: <publisher-name>National Institution of Science Communication</publisher-name>; <year>2000</year>:<fpage>243</fpage>.</mixed-citation></ref><ref id="bibr173-1559325818813227"><label>173</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Prajapati</surname><given-names>ND</given-names></name><name><surname>Purohit</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>AK</given-names></name><etal/></person-group>
<source>Handbook of Medicinal Plants</source>. <edition>1st ed</edition>
<publisher-loc>India</publisher-loc>: <publisher-name>Agrobios</publisher-name>; <year>2003</year>.</mixed-citation></ref><ref id="bibr174-1559325818813227"><label>174</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>T</given-names></name></person-group>, <article-title>Shiitake (<italic>Lentinus edodes</italic>): functional properties for medicinal and food purposes</article-title>. <source>Food Rev Int</source>. <year>1995</year>;<volume>11</volume>:<fpage>111</fpage>&#x02013;<lpage>128</lpage>.</mixed-citation></ref><ref id="bibr175-1559325818813227"><label>175</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Attele</surname><given-names>AS</given-names></name><name><surname>Wu</surname><given-names>JA</given-names></name><name><surname>Yuan</surname><given-names>CS</given-names></name></person-group>
<article-title>Ginseng pharmacology: multiple constituents and multiple actions</article-title>. <source>Biochem Pharmacol</source>. <year>1999</year>;<volume>58</volume>(<issue>11</issue>):<fpage>1685</fpage>&#x02013;<lpage>1693</lpage>.<pub-id pub-id-type="pmid">10571242</pub-id></mixed-citation></ref><ref id="bibr176-1559325818813227"><label>176</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Xiao</surname><given-names>Z</given-names></name></person-group>
<chapter-title>Podophyllotoxins and analogs</chapter-title> In: <person-group person-group-type="editor"><name><surname>Cragg</surname><given-names>GM</given-names></name><name><surname>Kingston</surname><given-names>DGI</given-names></name><name><surname>Newman</surname><given-names>DJ</given-names></name></person-group>, eds. <source>Anticancer Agents from Natural Products</source>. <publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>Brunner-Routledge Psychology Press, Taylor &#x00026; Francis Group</publisher-name>; <year>2005</year>:<fpage>71</fpage>&#x02013;<lpage>88</lpage>. <comment>Chap 5</comment>.</mixed-citation></ref><ref id="bibr177-1559325818813227"><label>177</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Han</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name></person-group>
<article-title>Progress in the research of blood activation and hemostasis removal</article-title>. <source>Abstr Chin Med</source>. <year>1988</year>;<volume>2</volume>:<fpage>466</fpage>&#x02013;<lpage>483</lpage>.</mixed-citation></ref><ref id="bibr178-1559325818813227"><label>178</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ra&#x00161;kovi&#x00107;</surname><given-names>A</given-names></name><name><surname>Stilinovi&#x00107;</surname><given-names>N</given-names></name><name><surname>Kolarovi&#x00107;</surname><given-names>J</given-names></name><name><surname>Vasovi&#x00107;</surname><given-names>V</given-names></name><name><surname>Vukmirovi&#x00107;</surname><given-names>S</given-names></name><name><surname>Mikov</surname><given-names>M</given-names></name></person-group>
<article-title>The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats</article-title>. <source>Molecules</source>. <year>2011</year>;<volume>16</volume>(<issue>10</issue>):<fpage>8601</fpage>&#x02013;<lpage>8613</lpage>.<pub-id pub-id-type="pmid">21993249</pub-id></mixed-citation></ref><ref id="bibr179-1559325818813227"><label>179</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Devi</surname><given-names>PU</given-names></name><name><surname>Akagi</surname><given-names>K</given-names></name><name><surname>Ostapenko</surname><given-names>V</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Sugahara</surname><given-names>T</given-names></name></person-group>
<article-title>Withaferin A: a new radiosensitizer from the Indian medicinal plant <italic>Withania somnifera</italic></article-title>. <source>Int J Rad Biol</source>. <year>1996</year>;<volume>69</volume>(<issue>2</issue>):<fpage>193</fpage>&#x02013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">8609455</pub-id></mixed-citation></ref><ref id="bibr180-1559325818813227"><label>180</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hecht</surname><given-names>S</given-names></name><name><surname>Kenney</surname><given-names>PM</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice</article-title>. <source>Cancer Lett</source>. <year>1999</year>;<volume>137</volume>(<issue>2</issue>):<fpage>123</fpage>&#x02013;<lpage>130</lpage>.<pub-id pub-id-type="pmid">10374832</pub-id></mixed-citation></ref><ref id="bibr181-1559325818813227"><label>181</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pisha</surname><given-names>E</given-names></name><name><surname>Chai</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>IS</given-names></name><etal/></person-group>
<article-title>Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis</article-title>. <source>Nat Med</source>. <year>1995</year>;<volume>1</volume>(<issue>10</issue>):<fpage>1046</fpage>&#x02013;<lpage>1051</lpage>.<pub-id pub-id-type="pmid">7489361</pub-id></mixed-citation></ref><ref id="bibr182-1559325818813227"><label>182</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nipun</surname><given-names>D</given-names></name><name><surname>Vijay</surname><given-names>S</given-names></name><name><surname>Jaykumar</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Antitumor activity of <italic>Dendrophthoe falcata</italic> against Ehrlich ascites carcinoma in Swiss albino mice</article-title>. <source>Pharm Crops</source>. <year>2011</year>;<volume>2</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref></ref-list></back></article>